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Abstract 
 
Background 
Antibiotic resistance is one of the major healthcare issues worldwide. Over time, bacteria are 
becoming more resistant, making antibiotics less effective, and this in turn will lead to an 
increase in the morbidity rate, the mortality rate, and the healthcare system expenses as well. 
The rise of antibiotic resistance is reaching critical levels as new mechanisms of resistance 
are emerging and spreading globally, limiting the available effective treatment options. In 
addition, biofilms are another significant health care issue: they act as a protective cover for 
infectious microbes. They are also hard to remove: they require a much higher dose of 
antibiotics than planktonic organisms. When treating biofilm-associated infections, it is 
important to understand the biology of biofilm development and biofilm-related gene 
expression. To understand the role of biofilm in pathogenesis, biofilm formation and gene 
expression in Escherichia coli CTX-M-15 were investigated in this study. The antivirulence 
efficacy of Manuka honey as an alternative treatment was analysed for this strain. 
 
Method 
Biofilm formation was measured using the Tissue Culture plate method at different times: 
after 6, 12, 24 and 48 hours of incubation. Assuming that times correlated with the stages of 
biofilm development, initial attachment occurred at 6 hours, microcolonies formed at 12 
hours, biofilm maturation occurred at 24 hours and biofilm dispersion occurred at 48 hours. 
Biofilms were quantified in both static and shaking incubators and under three different 
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growth media: nutrient-poor (AB broth), nutrient-rich (Luria-Bertani broth) and general 
(nutrient broth). A quantitative Polymerase Chain Reaction was used to determine the 
biofilm-related gene expression at the in vitro biofilm development stages. It was also used 
to determine the antivirulence effect of Manuka honey on select biofilm-related gene 
expressions. 
 
Results 
The tested strains showed a variable biofilm formation ability when using different media 
under static and shaking conditions. Antibiotic-resistant strains were high biofilm formers. 
Regardless of the incubation conditions and growth media used, E. coli CTX-M-15 formed 
varying amounts of biofilm which did not correlate with the stages of biofilm development. 
Similarly, the same pattern of biofilm-related gene expression was observed, with a large 
variation in the growth condition tested. 
Manuka honey showed potent antibacterial activity: the minimum inhibitory concentration 
was 6 %, the minimum biocidal concentration was 8 %, and the minimum biofilm elimination 
concentration was 5 %. The results of the qPCR showed that Manuka honey downregulated 
the expression of biofilm related genes.  
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Conclusion  
These findings suggested that, for both E. coli CTX-M-15 biofilm formation and biofilm-
related gene expression, the profiles were not affected by the growth conditions tested in this 
study. This confirms the successful role of biofilm formation in pathogenesis by adapting to 
different environmental conditions. The findings suggest that this plays a significant role in 
the increased prevalence in biofilm-associated infections in third-generation cephalosporin-
resistant E. coli CTX-M-15. 
Lastly, Manuka honey had powerful antibacterial and antibiofilm abilities and can be 
considered a reliable alternative therapy. 
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1.1 General Introduction 
 
Many researches have dealt with the prevalence of antibiotic resistance worldwide and have 
proposed temporary solutions, such as reducing the use of the currently effective antibiotics, 
ensuring cleanliness and preventing infection by vaccination; however, these solutions 
simply aim to slow down the progression of the problem but not to solve this global issue. In 
2018, the World Health Organization (WHO) reported that resistance development is 
‘critical’ in the carbapenem-resistant and extended-spectrum β-lactamase (ESBL) producing 
Enterobacteriaceae, which consists of pathogens associated with common infections, such 
as urinary tract infection; WHO categorised these pathogens as priority 1 pathogens that need 
global action to reduce the antibiotic resistance burden (World Health Organization, 2017). 
Conversely, inadequate research has focused on the characteristics that might contribute to 
antibiotic resistance; these characteristics include biofilm formation ability, which plays a 
vital role in the development of antibiotic resistance, in the transfer of the resistance genes 
among microcolonies within a biofilm layer, and in creating a highly efficient protective 
cover against the penetration of effective antibiotics (Li et al., 2018; Mah and O'Toole, 2001). 
In this work, several antibiotic-resistant strains were characterized. One of the characteristics 
that might contribute to antibiotic resistance is the ability of these pathogens to form biofilms. 
Therefore, this work investigated the biofilm formation ability of the pathogens in the 
phenotypic and genotypic contexts. The working hypothesis was that the selected strains are 
high biofilm formers. 
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1.2 Urinary Tract Infection (UTI) 
 
UTI is a collective term referring to any type of infection in the urinary tract (i.e. ureters, 
bladder, kidneys and urethra). The urinary tract is divided into two parts: the upper tract 
(ureters and kidney) and the lower tract (urethra and bladder) (Tan and Chlebicki, 2016). 
UTIs may be stratified as community-associated UTIs and healthcare-associated UTIs. 
Depending on the site of infection within the urinary tract, the infection is classified as 
cystitis, pyelonephritis or urosepsis. The exact epidemiological overview of UTIs remains 
lacking due to various limitations: firstly, due to the limited number of coordinated 
surveillance studies, and secondly, due to the inherent problems in the conduct of studies and 
in the definitions used in the available studies (Tandogdu and Wagenlehner, 2016). The 
members of Enterobacteriaceae are the most common cause of those infections, causing 
more than 70 % of UTI cases (Vranic et al., 2017). Among the members of this family, the 
Gram-negative Escherichia coli and Klebsiella pneumoniae are the most common causes of 
UTI worldwide. Data collected from many countries worldwide showed that E. coli causes 
70–95 % of the upper and lower UTI cases (Obiogbolu et al., 2009; Behzadi and Behzadi, 
2008; Ayhan et al., 1988; Ebie et al., 2001; Garofalo et al., 2007). Another microorganism 
that can cause UTI is Staphylococcus saprophyticus, which is involved in other UTI cases 
(Hooton and Stamm, 1997). Patients with diabetes, urinary catheters, hospitalization history 
or spinal cord injuries might also contract UTI caused by Proteus mirabilis, Enterococcus 
faecalis, Pseudomonas aeruginosa, Serratia marcescens and group B streptococci (Ronald, 
2002). E. coli causes approximately 80 % of the infections in the bladder (lower part of the 
urinary tract; this condition is termed cystitis). By contrast, K. pneumoniae causes up to 5 % 
26 
 
of community-acquired UTIs and is usually more common in diabetic patients and in 
nosocomial setting. Although K. pneumoniae commonly causes infection in the urinary tract, 
it is mostly identified as the cause of pneumoniae in compromised hosts (Rosen et al., 2008; 
Reid, 2018). 
UTI is among the most common types of infection. In 2013, approximately 92 million people 
worldwide were infected with UTI (Vos et al., 2015). Moreover, it is a significant cause of 
mortality among old aged people; in England and Wales, 4835 deaths due to UTI were 
reported in 2012 (Oxford, 2014). Moreover, UTI is more common in women than in men. In 
the UK, approximately half of all women are infected at least once in their life, whereas only 
1 in 2000 men will have such infections every year (University Hospital Southampton NHS 
Foundation Trust, 2019). According to WHO (2018a), the annual healthcare expenditure due 
to UTI reaches over $1 billion, and office visits reaches as high as 8.3 million.  
Because of the extensive use of antibiotics in UTI treatment, along with other factors, such 
as urinary catheterization, nursing home stay and hospitalisation history, antibiotic resistance 
in Enterobacteriaceae, mainly in E. coli and K. pneumoniae, has emerged and has 
significantly increased worldwide. Therefore, it is important to identify factors causing this 
resistance and its spread worldwide to minimize its risk and to reserve the usage of the current 
effective antibiotic among UTI patients (Mazzariol et al., 2017; Tenney et al., 2018). Biofilm 
formation plays a significant role in UTIs. It is responsible for recurrent infections and 
relapses in patients. Biofilms in UTIs usually form on catheters, and this phenomenon 
accounts for a high percentage of all nosocomial infections; also, biofilms are the most 
common cause of Gram-negative bacteria-associated bacteraemia in patients staying in 
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hospitals. For this reason, efficient prevention and control measures are urgently needed. 
Research on biofilms might lead to a deeper understanding and better knowledge on the 
disease process and will lead to the development of new treatment prevention options 
(Delcaru et al., 2016). As UTI is caused by bacteria, antibiotics are used to treat this infection. 
They can be prescribed by a doctor, and the type of antibiotic to be used depends on the 
species of the infectious bacteria. Nitrofurantoin is usually used as the first line of treatment 
(Antibiotic Research UK, 2019).  
 
1.3 Antibiotics  
 
Antibiotics are medications used to prevent and treat bacterial infections. They are natural 
metabolites produced by bacteria, fungi, plants and animals, and they are either bactericidal 
or bacteriostatic to microorganisms. Antibiotics display several mechanisms of actions, 
including: 
1) inhibition of bacterial cell wall synthesis (e.g. β-lactam antibiotics, such as 
penicillins, carbapenems, monobactams, and cephalosporins) (Fig 1.1).  
2)  inhibition of protein synthesis (e.g. aminoglycosides, macrolides and tetracyclines)  
3) inhibition of DNA synthesis (e.g. quinolones and metronidazole)  
4) inhibition of RNA synthesis (e.g. rifamycins)  
5) membrane structure disruption (e.g. polymyxins)  
6) inhibition of metabolic pathways (e.g. trimethoprim and sulfamethoxazole) (Zaman 
et al., 2017; Reid, 2018; Aminov, 2010).  
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1.4 ß-Lactam Antibiotics 
 
ß-lactams are widely used antibiotics and are the most effective drugs against bacterial 
infections. They are one of the three largest classes of antibiotics; ß-lactams include 
penicillin, cephalosporins, carbapenems and monobactams (Fig 1.1), which play a vital role 
in maintaining human health (Kotra and Mobashery, 1998; Fisher et al., 2005). These 
antibiotics are called ß-lactams due to the existence of a ß-lactam ring in their structures, and 
this ring represents their central activity (Worthington & Melander, 2013). The mechanism 
of action of ß-lactams involves the disruption of the cell wall synthesis by preventing the 
formation of the cross-links by the enzymes called penicillin-binding proteins (PBP); this 
action is achieved by mimicking the natural D-Ala-D-Ala (Fig 1.2) substrate of the PBP, 
thereby preventing cross-link formation between adjacent glycan chains (Fig 1.3) (Tipper 
and Strominger, 1965). 
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Fig 1.1 ß-lactam antibiotic structure. All ß-lactam antibiotics contain a ß-lactam ring, which is their core 
structure (as shown in the middle of the figure). The structure of the ß-lactam ring is similar to that of the 
terminal D-Ala-D-Ala peptide substrate, which is the penicillin-binding protein (PBP) that forms covalent 
bonds between different peptidoglycan chains during cell growth. The ß-lactam ring and associated side groups 
becomes tightly bound to the active site of PBP, which in turn inhibits its activity, preventing cell wall synthesis. 
Figures are adapted from Clarkson (2015). Chemical structures were drawn using chem-space.com.  
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Fig 1.2 The chemical structure of acyl D-Ala-D-Ala, which displays certain similarity with the structure of ß-
lactam ring. The figure is adapted from Clarkson (2015). The chemical structure was drawn using chem-
space.com.  
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Fig 1.3 Mechanism of action of ß-lactam antibiotics. Through a catalytic reaction, penicillin-binding protein 
(PBP) forms pentaglycine chains between the adjacent glycan chains, resulting in the removal of a terminal D-
alanine residue from one of the peptidoglycan precursors (indicated by a black arrow). Due to the structural 
resemblance of the ß-lactam ring to the D-Ala-D-Ala substrate for the PBP, ß-lactam ring binds tightly to the 
PBP. This binding prevents the formation of pentaglycine chains, resulting in the formation of cell wall that is 
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vulnerable to osmotic forces, possibly leading to cell rupture. NAG: N-acetylglucosamine, NAM: N-
acetylmuramic acid. Figure is adapted from Clarkson (2015).  
  
1.5 Antibiotic Resistance 
 
Antibiotic resistance is characterized by the change in bacterial response towards antibiotics, 
rendering these antibiotics ineffective. It occurs naturally, but it can be accelerated by 
antibiotic overuse, antibiotic misuse, and the lack of proper healthcare and new drug 
development industries in countries with poor economy and strict regulatory requirements 
(WHO, 2018b; Ventola, 2015). 
Resistance may occur through one of four mechanisms: (i) the ability to synthesize enzymes, 
such as β-lactamases, chloramphenicol acetyltransferases and aminoglycoside-modifying 
enzymes, which inactivate antibiotics (Fig 1.4); (ii) presence of efflux pumps in the 
cytoplasmic membrane; these pumps eliminate the antibiotic from the cell and prevent its 
binding to the target site; (iii) regulation of the number of porins, thereby limiting the access 
of antibiotics; and (iv) natural variation or acquired changes in the target sites of 
antimicrobials due to spontaneous mutation, affecting antibiotic binding (Kapoor et al., 
2017). 
Antimicrobial resistance may be due to natural evolution; in such a case, it does not relate to 
any class of antibiotics. For example, the complexity of the Gram-negative outer layer leads 
to a more difficult penetration of various types of antimicrobials. This phenomenon is called 
‘intrinsic resistance’. Another type of resistance, which can be more dangerous to humans, 
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is ‘acquired resistance’ wherein bacteria can develop resistance by acquiring specific 
resistance determinants via transformation, transduction or conjugation. This type of 
resistance may develop either between the same species or between different species. 
Moreover, acquired resistance, combined with mutation and selection via antibiotic pressure, 
enables the bacteria to rapidly adapt to the newly introduced antibiotic. (Kapoor et al., 2017; 
Reid, 2018) 
Antibiotic resistance represents a significant healthcare problem. The loss of the antibiotics’ 
effectiveness will weaken their ability to fight infectious diseases and to prevent the 
hospitalisation of patients as a result of the complications of chemotherapy, organ 
transplantation surgery and renal dialysis; in these patients, treatment of secondary infections 
is critical. Healthcare providers are compelled to use more toxic doses of antibiotics, and this 
approach is costly and becomes less effective when all options have been exhausted, that is, 
when the first- and second-line antibiotic treatments are rendered ineffective by antibiotic 
resistance or when they become unavailable (Centres for Disease Control and Prevention, 
2013). Increased incidence of antibiotic resistance in many pathogens was  reported in many 
places worldwide (Byarugaba, 2005). This increased resistance was attributed to the 
changing microbial characteristics, to selective pressure and to technological and societal 
changes that enhanced the development and spread of antibiotic-resistant microorganisms. 
Despite being a natural biological phenomenon, antimicrobial resistance developed due to 
the adaptation of infectious agents to the excessive use of antimicrobials and disinfectants 
for domestic or agricultural purposes (Walsh, 2000). 
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A breakthrough in the early 1980s involved the introduction of third-generation 
cephalosporin into the clinical practice. This breakthrough was the forerunner of the battle 
against the β-lactam-resistant strains. These cephalosporins were developed as a result of the 
increased resistance against β-lactam antibiotics, such as the ampicillin-hydrolysing β-
lactamases TEM-1 and SHV-1 in E. coli and K. pneumoniae and then diffused into new 
strains, such as Haemophilus influenzae and Neisseria gonorrhoeae (Paterson and Bonomo, 
2005). In 1983, a plasmid-encoded β-lactamase capable of hydrolysing extended-spectrum 
cephalosporins was first reported (Knothe et al., 1983). A mutation in a single nucleotide 
occurred in the gene encoding the β-lactamase compared with the gene encoding SHV-1. 
Other β-lactamases closely related to TEM-2 and TEM-1 were eventually discovered. These 
β-lactamases conferred resistance to the extended-spectrum cephalosporins (Brun-Buisson et 
al., 1987; Sirot et al., 1987). These new β-lactamases were named as extended-spectrum β-
lactamases (ESBLs). These ESBLs are fast-growing groups that can hydrolyse the third-
generation cephalosporins and aztreonam, but they are inhibited by clavulanic acid. These 
ESBLs formed through mutations in blaTEM-1, blaTEM-2 or blaSHV-1 that modify the 
configuration of the amino acid around the β-lactamase active site. This modification 
increased the susceptibility of β-lactam to hydrolysis caused by ESBLs. ESBLs are encoded 
by plasmids that frequently carry genes for resistance to other drugs, such as 
aminoglycosides. Thus, very limited options of antibiotics are available for treating ESBL-
producing microbes. Examples of ESBLs include CTX-M, SHV, TEM and OXA (Paterson 
and Bonomo, 2005).  
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Carbapenems are the best choice to cure the different types of infections caused by ESBL-
producing microbes. However, many isolates have been recently reported to be carbapenem-
resistant and what makes them distinct from other ß-lactams is the presence of carbapenems, 
along with the ß-lactam ring, in their molecular structure which confers them an additional 
stability against most β-lactamases, including ESBLs (Meletis, 2016). Carbapenem 
resistance is attributed to the production of β-lactamases that can inactivate carbapenems and 
other β-Lactam antibiotics; hence, they are called carbapenemases (Walsh, 2010; Poirel et 
al., 2007). These enzymes hydrolyse all or almost all β-lactams. They are encoded by genes 
that are transferred horizontally by transposons or plasmids; those transferable elements 
sometimes carry a gene code for other resistance determinants (Meletis, 2016). In terms of 
worldwide distribution and carbapenem hydrolysis, the most efficient carbapenemases are 
the IMP, NDM, KPC and OXA-48 types (Poirel et al., 2012).  
According to a recent study (Xue et al., 2016), antibiotic resistance is affected by what is 
termed ‘quorum sensing’ (QS) through the autoinducer-2 (AI-2). AI-2 upregulates the 
expression of the TEM-type enzyme in E. coli in a LsrR-dependent manner. 
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Fig 1.4 Mechanism of action of ß-lactamase. ß-lactamase hydrolyses the core structures of both penicillin and 
cephalosporin, which share a common four-atom ß-lactam ring. Hydrolysis of ß-lactam antibiotics prevents 
them from inhibiting bacterial cell wall synthesis. The figure was adapted from Clarkson (2015). The chemical 
structures were drawn using chem-space.com.  
 
1.5.1 ESBL 
 
ESBLs are ß-lactamases that confer its host a resistance against penicillins, cephalosporins 
(first, second and third generations) and aztreonam (except for carbapenems or cephamycins) 
through their hydrolysis, and ESBLs are inhibited by ß-lactamase inhibitors (e.g. clavulanic 
acid). Moreover, they are usually plasmid-encoded (Bush et al., 1995). 
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Among the ESBLs, the SHV-type (sulfhydryl variable) usually exists in clinical isolates more 
than any other types (Jacoby, 1997). SHV refers to sulfhydryl variable, as it was previously 
thought that the inhibition of its activity by p-chloromercuribenzoate was substrate-related 
and that it was variable according to the substrate used for the test (Sykes and Bush, 1982). 
As a result of amino acid changes that altered the conformation around the active site, the 
hydrolysing activity of SHV enzymes evolved from being narrow to being extended-
spectrum to include monobactams and carbapenems. Those ESBLs are usually encoded by 
plasmids that generally carry genes conferring resistance to other drugs, and they have 
become widespread in several members of Enterobacteriaceae worldwide (Liakopoulos et 
al., 2016). Thus far, 198 allelic variants of SHV have developed resistance to third-generation 
cephalosporin, and SHV-38 is a unique variant due to its expanded-spectrum that covers 
carbapenems (Poirel et al., 2003; Tzouvelekis and Bonomo, 1999). PCR-based methods and 
nucleotide sequence analysis remains the gold standard for the identification of extended-
spectrum β-lactamase SHV variants as these methods demonstrate a high sensitivity to 
variable gene expression levels. Meanwhile, standard microbiological procedures might take 
several days to perform (Bedenic et al., 2001; Bedenic et al., 2007; Singh et al., 2012; 
Stürenburg et al., 2003) 
The TEM-type (Temoneira ) of ESBLs were derived from TEM-1 and TEM-2, although both 
are not ESBLs (Datta and Kontomichalou, 1965; Buisson et al., 1987). The majority of TEM 
are encoded by Gram-negative bacteria, and 90 % of ampicillin resistance in Gram-negative 
bacteria is due to the TEM-encoding genes (Rice et al., 1990). Those ESBLs are usually 
plasmid-mediated and resulted from mutations in the classic TEM genes (TEM-1 and TEM-
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2) via a single or multiple amino acid substitutions around the active site. The first TEM 
(TEM-1) was isolated from E. coli in Greece in 1965 from a patient named Temoneira, and 
it was found to hydrolyse penicillin and the first-generation cephalosporins, such as 
cephaloridine. TEM-2 is similar to TEM-1 in its hydrolytic profile, but each one has different 
isoelectric point; therefore, they are not considered ESBLs (Steward et al., 2000; Zhao and 
Hu, 2013). The K. pneumoniae strain that was isolated in 1987 was found to carry a plasmid-
mediated β-lactamase termed CTX-1 because of its greater activity against cefotaxime. This 
enzyme later was renamed as TEM-3, and it was different from TEM-2 by double amino acid 
replacements (Alsterlund et al., 2009).  
CTX-M (cefotaxime) ß-lactamases are the widest disseminated enzymes. They were initially 
reported in the mid-1980s, and their occurrence has increased dramatically since 1995 
(Bonnet, 2004). It was discovered in 1986 in Japan and was denoted as a non-TEM, non-
SHV ESBL in E. coli strain resistant to cefotaxime (Matsumoto et al., 1988). Later, in 1989, 
a clinical cefotaxime-resistant E. coli strain was reported in Germany; this strain produces a 
non-TEM, non-SHV ESBL, which was denoted as CTX-M-1, indicating its hydrolytic 
activity against cefotaxime (Bauernfeind et al., 1990). Meanwhile, a rapid spread of a 
Salmonella strain carrying resistance to cefotaxime began in South America (Bauernfeind et 
al., 1992). CTX-M ß-lactamases are abundantly found in enterobacterial species worldwide. 
Besides being most active against cefotaxime in general, they exhibit little activity against 
ceftazidime. Based on their amino acid identities, they are grouped into five clusters, as 
follows: 1) CTX-M-1 cluster, which includes CTX-M-1, -3, -10, -11, -12 and -15; 2) CTX-
M-2 cluster, which includes CTX-M-2, -4, -5, -6, -7, -20 and TOHO-1; 3) CTX-M-8 cluster, 
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which includes CTX-M-8; 4) CTX-M-25 cluster, which includes CTX-M-25 and -26; and 5) 
CTX-M-9 cluster, which includes CTX-M-9, -13, -14, -16, -17, -19 and TOHO-2. The 
possible ancestors of the CTX-M-2 and CTX-M-8 clusters are the chromosomal ß-lactamases 
of Kluyvera ascorbate and K. georgiana, respectively (Boyd et al., 2004; Poirel et al., 2002). 
The ß-lactamase CTX-M-15 was firstly characterized by strains isolated from hospitalised 
patients in New Delhi. Those strains were E. coli, K. pneumoniae and Enterobacter 
aerogenes (Karim et al., 2001). CTX-M-15 differs from CTX-M-3 by a single amino acid 
change, that is, Asp240Gly (according to Ambler numbering), and both CTX-Ms are 
inhibited by clavulanic acid and tazobactam. However, unlike CTX-M-3, CTX-M-15 
displays a catalytic activity towards ceftazidime, and this finding may be a result of the 
Asp240Gly substitution (Ambler et al., 1991; Poirel et al., 2002). CTX-M-14 and CTX-M-
15 are the most important CTX-Ms within the CTX-M family as they are ubiquitous 
worldwide; the CTX-M-15 type is the most prominent type in the UK. The significance of 
this family is their multidrug resistance (MDR) ability, and many studies analysed their 
prevalence. However, insufficient studies dealt with their characteristics and their 
relationship with MDR (Cantón et al., 2012; Reid, 2018).  
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1.5.2 Carbapenemases 
 
Carbapenemases is the most versatile ß-lactamases family, and its broad spectrum is 
incomparable with that of other lactam-hydrolysing enzymes. A significant number of those 
enzymes recognize almost all hydrolysable lactams, even though they are known as 
carbapenemases. Moreover, many of them display flexibility against inhibition by all 
commercially available ß-lactamase inhibitors (Livermore and Woodford, 2006; Queenan 
and Bush, 2007). The first reported carbapenemases were isolated from Gram-positive 
bacilli. Compared with other ß-lactamases that were recognized during that period, 
carbapenemases were inhibited by EDTA. Therefore, they were recognized as 
metalloenzymes. Experiments showed that all metallocarbapenemases contain at least one 
zinc atom in their active site, which facilitates the hydrolysis of a bicyclic ß-lactam ring 
(Frère et al., 2005). Another set of carbapenemases rose in the mid- to late 1980s. Those 
enzymes’ activities were not inhibited by EDTA. Subsequent studies showed that these 
enzymes utilize serine at their active sites. Besides, the lactamase inhibitors clavulanic acid 
and tazobactam can inactivate them (Rasmussen et al., 1996; Queenan and Bush, 2007). 
Carbapenemases can be divided into three classes: class A, B and D. Class A consists of the 
serine carbapenemases, for example the K. pneumoniae carbapenemase (KPC); class B 
contains the metallo-β-lactamases (MBLs), for example  NDM (New Delhi metallo-ß-
lactamase) and IMP (Imipenem); and class D consists of the oxacillinase (OXA) 
carbapenemases, for example OXA-48 and OXA-23 (Queenan and Bush, 2007; Miriagou et 
al., 2010). 
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Detection of carbapenemases is critical for proper treatment. Different tests for phenotypic 
detection have been introduced, including the modified Hodge test, the inhibition tests for 
carbapenemase activity, and the detection of carbapenem hydrolysis (Miriagou et al., 2010). 
However, a test for accurate confirmation and identification of carbapenemases remains 
unavailable. This is because carbapenemase-producing bacteria, especially the members of 
Enterobacteriaceae, evoke a variety of carbapenem MIC distributions, which are sometimes 
under the breakpoint, or they have independent carbapenem mechanisms (e.g. active efflux 
pumping, porin alternations result in reduced permeability, and hyperproduction of class C 
β-lactamases or ESBLs) which run with or without carbapenemase activity. Furthermore, 
types within each class of carbapenemases (e.g. IMP and NDM) in MBL cannot be identified 
with phenotypic assays. Accordingly, a molecular confirmation is recommended for 
suspected carbapenemase-producing strains (Miriagou et al., 2010; Notake et al., 2013). 
OXA β-lactamases are always plasmid-mediated and are nearly rarely found; yet, those β-
lactamases were among the earliest β-lactamases that were detected. Usually, their mode of 
action is restricted to penicillins. However, some β-lactamases could act on cephalosporins. 
Since the 1980s, Acinetobacter baumannii isolates exhibiting carbapenem resistance and 
carrying plasmid-encoded β-lactamases have emerged; these β-lactamases were categorized 
as OXA enzymes due to being similar in sequence with earlier OXA β-lactamases, and they 
were denoted as OXA-23, OXA-40 and OXA-58. Later, it was discovered that all A. 
baumannii strains carry OXA β-lactamase in their chromosomes (OXA-51-like); when the 
genetic environment promotes its expression, many of them would confer resistance against 
carbapenems. Similarly, species of Acinetobacter that are closely related to A. baumannii 
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have their own chromosomally encoded OXA β-lactamases; many of these enzymes might 
have been transferred to A. baumannii and later formed the basis of transferable carbapenem 
resistance. In some occasions, OXA-48 β-lactamases have transferred to Enterobacteriaceae 
and have become a significant cause of carbapenem resistance. The evolution of OXA 
enzymes, which confer carbapenem resistance to A. baumannii, has lowered the potency of 
the carbapenems and has transformed these β-lactamases from a minor obstacle into a 
significant issue (Evans and Amyes, 2014).  
Another OXA type was identified in Istanbul in 2001; it was isolated from a MDR K. 
pneumoniae and it demonstrated carbapenem resistance; it was named OXA-48 (Poirel et al., 
2004). This enzyme, along with its variants, are currently broadly spread in K. pneumoniae 
along with other Enterobacteriaceae, also it was recently found in A. baumannii during a 
time that it was considered a major concern (Goncalves et al., 2013). Within the active site 
of OXA-48 and OXA-13, small changes are observed in the amino acid residues and in the 
β5-β6 loop of OXA-48, and such changes might be responsible for the enzyme’s ability to 
hydrolyse carbapenems, adding a hydrophilic environment to harbour water molecules that 
are required for hydrolysis. The carbapenem hydrolysis mechanism of OXA-48 differs from 
that of other carbapenem-hydrolysing oxacillinases. Besides, the active-site cleft of OXA-48 
contains a hydrophobic region larger than that of OXA-13 to facilitate diacylation by bringing 
the antibiotic into proximity with a water molecule. Those features indicate that OXA-48 has 
developed the ability to hydrolyse carbapenems by adapting a new evolutionary path 
compared with other OXA-type carbapenemases common in Acinetobacter species. The 
crystal structure of OXA-48 shows that it has a different carbapenem hydrolysis mechanism 
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compared with other carbapenem-hydrolysing oxacillinases (OXA-40 and OXA-23) in that 
in the active site of OXA-48 has no hydrophobic bridge. This characteristic suggests that 
there are other features responsible for its carbapenem hydrolysis ability (Docquier et al., 
2009; Evans and Amyes, 2014). 
IMP-type carbapenemases are the most prevalent MBL in Japan. It was recognized there in 
1991 in Serratia marcescens as IMP-1. Later, the IMP genes were detected in Canada and 
Brazil after being reported in Europe in 1997; subsequently, it slowly spread to the Far East, 
to the USA and to Australia. The IMP-type Carbapenemases were investigated extensively 
in Pseudomonas and Acinetobacter species, as well as in Enterobacteriaceae family. Up to 
18 IMP-type variants have been identified (Queenan and Bush, 2007; Bush and Fisher, 2011). 
IMP-1, IMP-2 and IMP-3 display a potent activity against β-lactam antibiotics, excluding 
monobactams. The activity of IMP-1 against carbenicillin is higher than that against 
ampicillin, whereas the activities of both IMP-2 and IMP-3 against the above drugs are 
similar (Watanabe et al., 1991; Livermore and Woodford, 2000).  
NDM-1 was mainly described in E. coli and K. pneumoniae, also 
in Pseudomonas and Acinetobacter but with less extent. It confers resistance to all β-lactam 
antibiotics, except aztreonam, and it is a novel MBL. However, some strains that carry 
blaNDM-1 are aztreonam-resistant, probably through a different resistance mechanism. This 
gene is carried on a plasmid that harbours multiple resistance determinants; therefore, it 
confers extensive drug resistance, allowing a few or no therapeutic choices (Fomda et al., 
2014; Yong et al., 2009; Castanheira et al., 2011). The first NDM-1 was reported in 2009 
when a Swedish patient (from Indian origion) who travelled from Sweden to New Delhi, 
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India had contracted UTI through an infection with carbapenem-resistant K. pneumoniae that 
was resistant to all tested antibiotics, excluding colistin (Yong et al., 2009). NDMs are the 
most relevant enzymes within the MBL family and have been described to have high 
dissemination tendencies, i.e. tremendous ability to spread. A few variants of NDM, such as 
NDM-4, NDM-5 and NDM-7, hydrolyse carbapenem more efficiently. The interactions of 
NDMs with other resistance determinants represent a serious threat for therapy (Sahuquillo-
Arce et al., 2015; Rolain et al., 2010). A multinational team published in The Lancet in its 
August 2010 issue a report on the spread and emergence of 180 cases of patients harbouring 
the NDM-1-carrying strain. Also, 37 cases from the UK and 143 from India and Pakistan 
were reported, suggesting a widespread dissemination of the carbapenemase (Kumarasamy 
et al., 2010). Moreover, the highest occurrence of carbapenemase gene was observed in many 
African countries, including Kenya, Morocco and South Africa (Poirel et al., 2011; Codjoe 
and Donkor, 2018). The identification of NDM-1 gene in E. coli and in K. pneumoniae 
suggests the possibility of in vivo conjugation (Yong et al., 2009).  
The most relevant among class A carbapenemases (plasmid-encoded) are KPCs. Not only do 
they hydrolyse nearly all β-lactams, but they are also inserted into mobile genetic elements 
carrying antimicrobial resistance genes other than β-lactams (Yigit et al., 2001; Sahuquillo-
Arce et al., 2015). Twenty types of KPCs have been described. They differ by 1–3 amino 
acid substitutions and show different hydrolysis profiles (Walther-Rasmussen and Høiby, 
2007). KPCs efficiently hydrolyse cephaloridine, benzylpenicillin, cefalotin, amoxicillin, 
piperacillin and nitrocefin. They can also hydrolyse aztreonam, meropenem, imipenem and 
cefotaxime but at an activity that is lower by 10-fold to the penicillins and early 
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cephalosporins. Notably, KPCs show weak hydrolysing activity on cefoxitin and ceftazidime 
(Queenan and Bush, 2007). blaKPC was first identified in K. pneumoniae in the USA and it 
eventually spread worldwide in other Enterobacteriaceae and non-fermenting Gram-
negative bacteria. The dissemination of blaKPC became an endemic issue in Colombia, Puerto 
Rico, Italy, Greece, Israel, in the east coast of the USA and in the east coast of China; regional 
or local outbreaks were reported worldwide afterwards. The inter-general spread and high 
adaptability of KPCs were demonstrated during the first KPC-3 outbreak in Canada between 
2009 and 2010, wherein five Enterobacteriaceae species were involved (Leung et al., 2012; 
Munoz-Price et al., 2010; Sahuquillo-Arce et al., 2015). In the KPC group, KPC-3 was the 
most recent enzyme to be reported. It is closely related to the formers KPC-1 and KPC-2, to 
which it differs in two and one amino acid, respectively. It was isolated from K. pneumoniae, 
E. coli and Enterobacter cloacae. KPC-3 hydrolyses carbapenems, cephalosporins, 
penicillins and even sulbactam. Cephalothin is the best substrate for KPC-3 (Bratu et al., 
2005; Alba et al., 2005). 
Another virulence factor that has a significant role in antibiotic resistance is the ability of 
bacteria to form biofilm. Bacterial community within a biofilm can resist the antimicrobial 
effects and display a high survival rate even when they are antimicrobial-sensitive as there 
are several mechanisms supporting the multi-factorial antibiotic resistance. Moreover, gene 
exchange, especially the resistance genes, might happen within the biofilm, which in turn 
might add another role for biofilms in the development of antimicrobial resistance (Stewart 
and Costerton, 2001; Singh et al., 2017). Thus, this study combines the antibiotic-resistance 
criteria with biofilm formation ability for the analysis of specific antibiotic-resistant isolates. 
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1.6 Microbial Biofilm 
 
Biofilm is defined as a microbial community irreversibly attached to a biological or synthetic 
surface and lodged in a matrix formed of extracellular polysaccharide, proteins, and 
extracellular DNA (Soto, 2014; Fattahi et al., 2015; Wolska et al., 2015; Anderson et al., 
2004). 
Biofilm formation (Fig 1.5) occurs in five steps (Stoodley et al., 2002, Soto, 2014), as 
follows:  
i) planktonic cells reversibly attach to a surface; 
ii) irreversible attachment of planktonic cells to a surface mediated by exopolymeric 
material formation; 
iii) formation of biomolecular complex layer and secretion of exopolysaccharides 
that constitute the outer layer; biofilm maturation starts at this stage; 
iv) formation of three-dimensional biofilm structure containing macrocolonies in 
clusters; within clusters, channels are formed to allow water and nutrient transport 
and to facilitate elimination of wastes; and 
v) after maturation, detachment of biofilm occurs, allowing cells to spread by taking 
the planktonic form and by reattaching to other surface(s) and form a new biofilm. 
Bacteria may exist in two forms during their proliferation and growth: planktonic (as  single 
and independent cells) or ordered ‘sessile’ aggregates (i.e. the biofilm). During their 
planktonic form, bacterial infections are mainly curable with traditional antibiotics; this kind 
of infection is termed acute infection. By contrast, the untreatable infection involves biofilm 
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formation and termed chronic infection, where bacteria mainly have their ultimate resistance 
to antibiotics and to other traditional antimicrobial agents (Bjarnsholt, 2013).  
 
 
 
Fig 1.5 Step in biofilm formation: the process starts when planktonic cells aggregate and reversibly attach to a 
surface (1); the cells start to form exopolymeric materials and attach irreversibly (2); the biofilm starts to mature 
by forming a complex layer of biomolecules and through the secretion of exopolysaccharides (3); the mature 
biofilm with a three-dimensional structure contains macrocolonies clusters interspersed by channels for nutrient 
and waste transfer (4); after maturation, the biofilm cells detach and spread (5).  
 
Atshan et al. (2013) studied the biofilm formation steps in Staphylococcus aureus by using a 
scanning electron microscopy at four time points of growth (i.e. 6, 12, 24, and 48 h); they 
noticed that mesh-like structures started to appear after 12 h of growth, and the structures 
became denser at 24 and 48 h with fibrous materials. 
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Sessile cells differ from planktonic cells physiologically and phenotypically, and their 
increased resistance to antimicrobial agents is one of their important characteristics (Donlan 
and Costerton, 2002, Mah and O'Toole, 2001, Stewart and Costerton, 2001). Biofilm 
formation represents a significant challenge due to its hidden role in the failure of 
antimicrobial therapy, and nearly 65–80 % of all infections are presumably related to biofilm 
(Costerton et al., 1999; Parsek and Singh, 2003; Hall-Stoodley et al., 2004).  
The physiology of microcolonies and biofilm structure confer inheritable resistance to 
antimicrobial agents. There are three possible mechanisms to which resistance can be 
attributed: (i) biofilm matrix can delay the penetration of the antimicrobial agent; (ii) 
microcolonies slow down their growth rate; and (iii) some physiological changes related to 
the biofilm mode of growth, such as nutrient limitations and toxic metabolite accumulation, 
which induce stress response genes and eventually promote the formation of high-density 
biofilms, improve cell viability (Donlan and Costerton, 2002). 
Biofilms can colonize biotic and abiotic surfaces and can exert useful or harmful impacts to 
human health, to the environment and to the industry (Costerton et al., 1987). The biofilm 
structure, namely, its polymeric matrix and adhesive surface, provides cells with high water 
concentration and nutrition and is an ideal avenue for signalling pathway, enzyme and 
metabolite interaction and exchange of genetic materials(Davey and O'Toole G, 2000). 
Biofilm-associated cells are characterized by increased resistance to the host immune system, 
to detergents and to antibiotics; they can also adapt to environmental changes and adverse 
environmental conditions, such as low pH, desiccation, limited nutrient supply and predation. 
Moreover, a biofilm can provide cells with conditions characterized by high osmolarity, high 
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cell density and low oxygen supply (Lewandowski et al., 1991; Vieira et al., 2004; Prigent-
Combaret et al., 1999; Stewart and Franklin, 2008; Rinaudi and Giordano, 2010). Astronauts 
may suffer from compromised immune systems that drive them to be easy victims of bacterial 
infections. This is because bacteria are not only able to survive in space but also can 
proliferate and become virulent. The International Space Station has been demonstrated to 
be contaminated with bacterial biofilms and slime (Nickerson et al., 2004, Kim et al., 2013). 
Regarding the industrial aspects, biofilm can have some hazardous impacts; for instance, 
biofilms act as heat exchangers, and biofouling becomes a major problem when marine ship 
cages and ship hulls come into contact with water (Braithwaite and McEvoy, 2005; Coetser 
and Cloete, 2005; Flemming, 2002). Moreover, formation of biofilm in drinking water tanks 
directly affects human health. In this case, biofilms might block these systems as well as serve 
as a health risk to consumers by providing a shelter for pathogenic bacteria, such as E. coli 
and Legionella pneumophila (Flemming, 2002; Juhna et al., 2007). However, there are 
considerably useful applications of microbial biofilms, including fermentation (Kunduru and 
Pometto, 1996), bioremediation (Singh et al., 2006), production of biofuel (Wang and Chen, 
2009), electricity generation using microbial fuel cells (Rabaey et al., 2007), fine chemical 
production (Li et al., 2006) and wastewater treatment (Nicolella et al., 2000). 
Biofilm complexity is made even more complicated by their being genetically heterogeneous 
(Stewart and Franklin, 2008). Biofilm could be stratified (in its natural community) which is 
caused by the migration of its resident microorganisms towards the areas with optimal 
conditions to gain light, secondary metabolites, nutrients, oxygen and signalling compounds 
(Becraft et al., 2011; Kim et al., 2014; Ramsing et al., 2000). There are three general factors 
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that contribute to biofilm heterogeneity: (i) Physiological heterogeneity, wherein bacteria 
adapt to the environmental conditions. For instance, oxygen and nutrients diffuse from the 
source into the biofilm and become available to the bacteria for utilization. Such a diffusion 
will cause the development of a chemical concentration gradient, which in turn might interact 
with the gradients for waste products and signalling compounds, Resulting in formation of a 
variety of unique microenvironments in the same biofilm structure, ultimately resulting in a 
growth condition that differs completely from that for planktonic bacteria. The bacteria in 
turn respond to the changing conditions and thus the physiology of the individual cells may 
differ from that of the nearby cells (Rani et al., 2007; Rasmussen and Lewandowski, 1998; 
Werner et al., 2004). (ii) Genetic variability, wherein mutation might occur in a clonal 
population of cells. This phenomenon might cause cellular differentiation (Boles et al., 2004; 
Hansen et al., 2007). (iii) Stochastic gene expression, wherein the same genes are expressed 
at different levels among groups of cells, though these cells are exposed to the same 
environmental conditions. This phenomenon leads to the development of subpopulation of 
cells within the same community, and these cells differ from the mother cells in a way that 
the persister cells display a better antibiotic resistance than the other members of the same 
community (Baty et al., 2000a, Baty et al., 2000b, Vlamakis et al., 2008, Gelens et al., 2013). 
Investigation on biofilms is usually performed in the natural environment and in laboratory-
scale bioreactors designed to simulate a natural biofilm. Bioreactors are operated in two 
ways: under static conditions or under continuous flow conditions. In the first case, bacteria 
in a biofilm may be subjected to growth phases (lag phase, log phase and stationary phase), 
the same as in growing planktonic cultures in vitro. For continuous cultures, the process is 
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usually done under ‘wash-out’ conditions wherein the residence time of the bacterial cell is 
shorter than its doubling time. Residence time is defined as the ‘time for one reactor sized 
volume of liquid to flow through the reactor’. In this approach, all planktonic cells are washed 
out from the reactor, and only the bacteria that adhered to the surface are kept within the 
reactor. In this kind of bioreactors, usually the biofilm surfaces are either a coupon that could 
be easily removed from the reactor for later analysis or the walls of the reactor could be 
directly imaged (Franklin et al., 2015; Coenye and Nelis, 2010; BioSurface Technologies 
Corp, 2016).  
 
1.6.1 Biofilm and UTIs 
 
In UTI, biofilm formation involves many processes following infection. The main cause of 
biofilm formation is catheterization, which induces a robust immune response leading to the 
accumulation of fibrinogen on the catheter; the fibrinogen in turn creates an ideal 
environment to attach the uropathogens that express fibrinogen-binding proteins. Neutrophil 
infiltration will be induced by this infection. After the initial attachment of bacteria onto the 
fibrinogen-coated catheter, the bacteria multiply, forming biofilms and subsequently 
promoting epithelial damage; the kidneys will be seeded by infection wherein toxin 
production will induce tissue damage. The infectious microorganisms that cause complicated 
UTIs can also progress to bacteraemia by crossing the tubular epithelial cell barrier if they 
are left untreated (Flores-Mireles et al., 2015).  
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1.6.2 Biofilm analysis 
 
Static biofilms (Fig 1.6) have been used in some biofilm studies. The simplest method to 
facilitate growth of and to screen biofilm was developed by O’Toole and co-workers (1998). 
In this method, bacterial strains are incubated in a microtiter plates’ wells. After incubation, 
the cells are washed out, and the remaining cells associated with the wells are stained with a 
colorimetric indicator (e.g. crystal violet); the amount of crystal violet taken up by the cells 
is assayed to estimate the biofilm amount. This method can be used to compare the amount 
of biofilm produced by the wild-type strains and the mutant strains to study the effect of gene 
deletion or mutation on biofilm formation and on bacterial adhesion onto the surfaces 
(O'Toole and Kolter, 1998a, O'Toole and Kolter, 1998b). Another method that involves the 
use of microtiter plates and which is a modification of the method above involves the use of 
the Calgary Device. In this method, the biofilm that grows on the pegs that were immersed 
in the wells of the microtiter plates is assayed rather than the organisms growing on the wells. 
This method minimizes the interference of planktonic cells that might remain at the bottom 
of the wells following washing but are not biofilm bacteria; in this way, only the peg-adherent 
bacteria are assayed (Ceri et al., 1999). Biofilms may be cultivated under static conditions 
either on coupons placed in the wells of microtiter plates or as pellicles at the air–water 
interface. Some organisms prefer to grow under static conditions and form thick biofilms, 
whereas they do not form intrinsic biofilms when grown under continuous flow. This 
technique might reflect the preference of some organisms under static conditions where they 
are found in their natural habitat (Branda et al., 2001; Chimileski et al., 2014). 
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Colony biofilm might be used as another type of static biofilm. In this approach, biofilms are 
cultivated on filters placed on agar Petri plates’ surface. The filters are subsequently 
transferred into a new fresh medium at regular intervals, and the biofilms are given a semi-
continuous supply of fresh nutrients. The greatest benefit of this method is that biofilms are 
easy to grow using cheap laboratory techniques. This method is usually used in 
cryoembedding and in thin sectioning experiments given that the biofilm generated using this 
method is thick (Huang et al., 1996). The disadvantage of this method is that since there is 
no wash-out process, planktonic cells might interfere with the biofilm assay (Franklin et al., 
2015). 
 
 
In simulating natural biofilms, continuous flow reactors (Fig 1.7) have been developed for 
advanced biofilm studies. The reactors used for continuous flow include the Centre for 
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Disease Control (CDC) biofilm reactor (Goeres et al., 2005), the drip-flow reactor (Goeres 
et al., 2009) and the reactors designed for confocal laser scanning microscopy (CLSM) 
imaging (Lawrence et al., 1991; Nivens et al., 2001; Stapper et al., 2004). The CDC biofilm 
reactor is a perfectly large-scale reactor that supplies ports for medium inlet and outlet. The 
chamber contains rods carrying removable coupons made of glass, metals or hydroxyapatite. 
In this bioreactor, the biofilm is formed on the surface of the coupons and then removed 
aseptically over time. This technique is used for direct imaging of the sample using CSLM, 
for determining colony-forming units and direct bacterial cell counts, and for omics studies. 
The biofilm formed by this method is usually thick and mimics natural biofilms; these 
characteristics are achieved by running the CDC biofilm reactors under wash-out conditions 
with fluid shear. However, one disadvantage of this method is that the reactors need a large 
medium tank, making it a low-throughput technique (Goeres et al., 2005). The drip-flow 
reactor is similar to a continuous flow reactor. In this case, the medium is dripped onto the 
coupon surface and then allowed to flow over the coupon. In the drip-flow reactor, the 
resulting biofilms are often thick. Also, the reactor creates an excellent mimic for some 
natural biofilms in that the fluid flows across the surface with an air interface. In this 
technique, the biofilms usually show some heterogeneity across the slide from the initial site 
of the medium input to the outlet. This method allows the conduct of studies related to 
cryoembedding and thin sectioning (Goeres et al., 2009; Lenz et al., 2008; Xu et al., 2001). 
The imaging flow cells system is another form of a continuous flow reactor. The flow cells 
usually contain a window, which is made of a glass coverslip that permits viewing of the 
biofilm under a microscope. These biofilms can be imaged using CSLM that reveals the 
three-dimensional architecture of the biofilms. A modification of this technique is the 
55 
 
capillary flow cell biofilm wherein the biofilms are cultured in small square capillary tubes. 
In this technique, the biofilms that form on the walls of the capillary tubes can be directly 
imaged. A challenge for this approach is the formation of clog inside the small tubes. 
Therefore, this technique is suitable only for short-term experiments (Lawrence et al., 1991; 
Nivens et al., 2001; Stapper et al., 2004; Dunsmore et al., 2002; Rani et al., 2005; Xi et al., 
2006).  
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1.6.3 Genes involved in biofilm formation in E. coli 
 
In addition to environmental factors, such as pH, temperature, ionic force of the medium and 
surface nature, genetic signals control every step in the process of biofilm development and 
maturation (Roux et al., 2010). Niba and co-workers (2007) have identified many genes 
involved in biofilm formation in E. coli k-12 strain.  
crr codes for a protein product, Crr, which is involved in glucose transport, along with 
another protein (PtsG) by forming an enzyme complex known as the enzyme II complex. 
The PtsG/Crr picks up the exogenous glucose and releases its phosphate ester into the cell 
cytoplasm in preparation for metabolism by glycolysis (Curtis and Epstein, 1975; Weigel et 
al., 1982). 
Genes that codes for curli are distributed in two operons: csgBA and csgDEFG (Fig 1.8). The 
csgBA operon encodes the subunits of curli proteins that form fibres at the cell surface; these 
fibres are called fimbriae, which are involved in adhesion and cell–cell attachment 
(UniProtKB, 2019f). CsgA is the major subunit protein of the fibre, whereas CsgB is the 
nucleator protein homologous in sequence to CsgA. Both are encoded by the csgBA operon. 
CsgA is secreted outside of the cell and then CsgB nucleates it into a fibre. When CsgB is 
absent, the curli are not assembled and CsgA is secreted in an unpolymerized form from the 
cell. CsgG is an outer membrane protein and it is needed for the secretion of the two curli 
structural subunits (i.e. CsgA and CsgB). CsgE and CsgF are periplasmic proteins that 
interact with CsgG in the outer membrane. CsgE, CsgF and CsgG promote the secretion and 
assembly of CsgA into a fibre. CsgD is a positive transcriptional regulator of the csgBA 
operon (Hammar et al., 1995; Barnhart and Chapman, 2006). 
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fliS codes for the flagellar protein FliS, which is the flagellin-specific chaperone that binds 
flagellin (the major protein of the filament) and facilitates its export. It also plays a significant 
role in motility (Galeva et al., 2014; Juhas et al., 2014).  
fliL is another flagellar protein located in an operon, along with other genes that code for 
export apparatus and motor/switch proteins for flagellar development. An E. coli carrying a 
deletion mutation in fliL will generate a cell defective in swarming motility but not in 
swimming motility. The lack of fliL will lead to a single flagellar motor that rotates at reduced 
speeds and switches directions less frequently. It also plays an essential role in torque 
generation, particularly at high viscous loads (Partridge et al., 2015; Attmannspacher et al., 
2008). 
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Fig 1.8 A schematic diagram illustrating the two curli gene operons; csgBA and csgDEFG. CsgD positively 
regulates the csgBA operon. The outer membrane protein (CsgG) is required for the secretion of the two curli 
structural subunits CsgA and CsgB. CsgE and CsgF will interact with CsgG and are needed for efficient curli 
assembly. CsgB nucleates CsgA into a fiber when the latter secreted outside of the cell. The diagram is adapted 
from Barnhart and Chapman (2006). 
tolB gene is a part of the tol-pal gene cluster that codes for seven genes, which are organized 
in an operon with an internal promoter. The proteins encoded by the tol-pal gene cluster 
participate in supporting the integrity of the cell envelope, but their precise task in the cluster 
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remains ambiguous. Mutation in this gene cluster results in a leaky membrane, in defective 
cell division and in defective sensitivity to detergents and antibiotics. tolB is one of the 
transcripts derived from the gene product of this operon, and it is a periplasmic protein 
(Lazzaroni et al, 1999; Llamas et al, 2000; Sturgis, 2001).  
The protein product of yieO is proposed to function as a multidrug transmembrane 
transporter, although insufficient studies confirm the exact function of this gene (Kvist et al., 
2008). 
mdoH is involved in the biosynthesis of a protein called osmoregulated periplasmic glucan 
(OPG). OPG is required in the pathway which is part of glycan metabolism for OPG 
biosynthesis (UniProtKB, 2019a). On gene expression work on the plant pathogen Xylella 
fastidiosa during biofilm formation, De Souza et al. (2004) found that this gene is 
upregulated during biofilm maturation.  
fimA is the major subunit of the E. coli type 1 fimbriae (pili). It plays a function in cell 
adhesion and pilus organization. Moreover, it has a role in single-species biofilm formation 
via attachment to abiotic surfaces (UniProtKB, 2019g; Roux et al., 2010). 
rfaH affects the expression of different operons that encode extracytoplasmic components in 
E. coli. It enhances the expression of different factors that play a significant role in virulence. 
Inactivation of rfaH significantly decreases the virulence of uropathogenic E. coli. rfaH 
represses biofilm formation by reducing the antigen 43 (Ag43) level. Ag43 mediated auto 
aggregation and biofilm formation and it is encoded by flu, wherein rfaH has been shown to 
indirectly downregulate the expression of flu (UniProtKB, 2019g; Beloin et al., 2006). 
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Accordingly, the expression of the above genes regulates biofilm formation and contributes 
to microorganisms’ ability within the biofilm to resist the antimicrobials via a variety of 
mechanisms; such as coordination with other genes that function in decreasing antimicrobials 
diffusion into the biofilm matrix, production of exopolysaccharides that confer chlorine 
resistance, and reduction of microbial growth rate (Watnick and Kolter, 2000). 
Moreover, the regulatory effects of the QS mechanism coordinate the heterogeneous 
architecture of biofilm and regulate the synthesis of degradative enzymes and facilitate the 
new mode of growth of microcolonies within the biofilm (Hassett et al., 1999). Many genes 
studied in this work, such as motB, crl, and nlpC, which contribute to biofilm formation are 
regulated by QS mechanisms (DeLisa et al., 2001). 
 
1.7 Quorum sensing 
 
QS is defined as the regulation of gene expression according to microbial cell density 
population fluctuation (Miller and Bassler, 2001). It enables bacteria to communicate, 
integrate, sense, respond to changes in their environment, and it coordinate these responses 
within the cell population using chemical molecules termed as autoinducers (Fuqua et al., 
2001). A QS system regulates many Gram-positive and Gram-negative bacterial 
physiological activities, such as virulence, sporulation, competence, symbiosis, antibiotic 
production, conjugation, motility, light production, bioluminescence and biofilm formation 
(Miller and Bassler, 2001; Kaper and Sperandio, 2005; Visick and McFall-Ngai, 2000; 
Whitehead et al., 2001). During bacterial growth, the extracellular signals (i.e. the 
61 
 
autoinducer (AI) molecules) are produced and detected by the same bacterial groups or by 
other microorganisms to determine the cell population density. AIs have been classified into 
two main types: AI-1 and AI-2. AI-1 molecules are acyl homoserine lactones (HSLs). They 
are assumed to play as intra-species signals. By contrast, AI-2 is a DPD-derived molecule 
(DPD is 4,5-dihydroxy-2,3-pentanedione) and functions in inter-species communication. 
Synthesis of AI-1 depends on LuxI-like synthases and on the combination between LuxR-
like transcriptional regulator protein with its cognate HSL. This combination (LuxR–HSL 
complex) then stimulates the target gene transcription and expression of the related 
physiological functions. AI-2 is synthesized by LuxS-like synthases and recognized by LuxP 
and LuxQ; a phosphorylation-relay cascades then transmits the signal and activates the target 
gene transcription and the consequent physiological behaviour of many Gram-positive and 
Gram-negative bacteria (Miller and Bassler, 2001; Withers et al., 2001; Camilli and Bassler, 
2006; Xavier and Bassler, 2003). 
 
1.7.1 AI-2 and related QS circuit 
 
AI-2 is a common inter-species signal that enables one species to identify other species’ cell 
population densities. It is a furanosyl borate diester and relies upon LuxS-like synthases for 
its synthesis. In the AI-2 QS circuit, AI-2 is recognized by LuxP and LuxQ proteins; a 
phosphorylation cascade then starts, in which a signal is transmitted, and transcription of the 
target gene is activated (Xavier and Bassler, 2003). Peptide signalling molecules are utilized 
instead of HSLs as QS signals in Gram-positive bacteria; the signals are transported via a 
mechanism involving a two-component system. Examples of activities controlled by such 
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kind of QS are virulence factors and genetic competence (Kleerebezem et al., 1997; Bassler 
and Losick, 2006; Sturme et al., 2002).  
QS regulated by AI-2 is widely spread among many Gram-negative and Gram-positive 
bacteria (Xavier and Bassler, 2003). The bioluminescence of Vibrio harveyi was the first cell 
function reported to be controlled by AI-2 (Greenberg et al., 1979; Pereira et al., 2013). 
Biofilm formation in Streptococcus mutans and Salmonella typhi and the virulence factor 
expression in Vibrio cholera have also been reported to be mediated by AI-2. (Merritt et al., 
2003; Pratt and Kolter, 1998; Zhu et al., 2002). In addition, AI-2 was reported to control 
Type III secretion in enterohaemorrhagic E. coli (Sperandio et al., 1999), transcriptional 
virulence gene expression in Clostridium difficile (Lee and Song, 2005), Clostridium 
perfringens alpha, kappa and theta toxins (Ohtani et al., 2002), prodigiosin, secreted 
haemolysin and biosynthesis of carbapenem antibiotics in Serratia marcescens(Coulthurst et 
al., 2004). For some bacterial species, a luxS mutation leads to an altered structure or 
decreased biofilm volume in comparison with the correlated wild-type strains, such as in S. 
typhi (Prouty et al., 2002), S. mutans (Merritt et al., 2003) and K. pneumoniae (Balestrino et 
al., 2005). In E. coli, the role of AI-2 differs among various strains; for instance, it regulates 
motility in K12 strains (Herzberg et al., 2006; Wood et al., 2006), whereas it plays a 
metabolic role in O157:H7 (Clarke and Sperandio, 2006, Walters and Sperandio, 2006). 
However, it was found that AI-2 in K. pneumonia plays a role in the early stages of biofilm 
formation (Balestrino et al., 2005). 
In E. coli, synthesis of AI-2 depends on the quantity of carbohydrate in the medium and is 
subjected to the growth phase. Production and secretion of AI-2 by cells occur during the 
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exponential growth phase, whereas AI-2 is no longer produced in the stationary phase 
(Surette and Bassler, 1998; Cappuyns et al., 2009). It was reported that AI-2 signal was not 
produced in the absence of glucose (Surette and Bassler, 1998; Surette et al., 1999). 
Moreover, DeLisa et al. (2001) reported that AI-2 production was stimulated by the addition 
of glucose, iron and NaCl in the nonpathogenic E. coli strains. Also, in LB medium, AI-2 
was produced with or without the addition of glucose. This finding indicates that glucose is 
non-essential for AI-2 synthesis, although it can increase its production. Niu et al. (2013) 
reported that LuxS might affect E. coli biofilm production and other phenotypes in two ways: 
through production of AI-2 signal and through AI-2-independent modification of 
intracellular metabolite levels.  
The loss of AI-2 at the stationary phase is due to its uptake by E. coli as it is imported through 
an ATP-binding cassette (ABC) transporter, which is called the luxS-regulated (Lsr) 
transporter. lsr operon (lsrACDBFG) is regulated by cyclic AMP/cyclic AMP receptor 
protein, and the transporter proteins are a part of this operon. The genes lsrK and lsrR are 
located upstream of lsr, and both belong to the same operon, lsrRK, which is positively 
regulated by cyclic AMP receptor protein and negatively regulated by LsrR. AI-2 is 
phosphorylated to an activated molecule by the cytoplasmic kinase LsrK, which in turn 
thought to bind and derepress the lsr repressor LsrR (Li et al., 2007; Wang et al., 2005). The 
mechanism of action of this AI-2 QS circuit is illustrated in Fig (1.9) 
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Fig 1.9 The LsrR/phospho-AI-2 circuit during AI-2 uptake in E. coli. LsrR supresses an lsr operon, 
lsrRK operon, along with other genes. LsrACDB imports AI-2 into the cell, which in turn will be processed as 
phospho-AI-2 via the kinase LsrK. Studies showed that phospho-AI-2 binds LsrR and relieves its repression of 
the lsr transporter genes and thus triggers their expression, which in turn triggers additional AI-2 uptake (Li et 
al., 2007). 
 
Studies showed that E. coli has an AI-2-mediated QS system that might regulate its virulence 
factors, DNA processing, cell division, flagellar development, motility and biofilm formation 
(Sperandio et al., 2002). In E. coli, AI-2 controls the expression of some genes that plays 
different functions (DeLisa et al., 2001). motB expression, which is controlled by AI-2, is a 
transmembrane protein that functions in transmembrane proton conduction. Along with the 
products of motA, both genes’ products comprise the stator element of the flagellar motor 
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complex that is required for the rotation of the flagellar motor, which is operated by H+ ion 
gradient across the cytoplasmic membrane (Zhou et al., 1998; UniProtKB, 2019e; Sowa et 
al., 2014).  
 The protein product of crl binds to the sigma-S subunit of RNA polymerase, increases the 
activity of RpoS by direct interaction with the RpoS holoenzyme, and activates the 
expression of sigma-S-regulated genes, such as the csgBA operon, which encodes the 
subunits of curli proteins that form fibres at the cell surface; these fibres are called fimbriae 
that are involved in adhesion and cell–cell attachment (Cavaliere and Norel, 2016; Arnqvist 
et al., 1992; Pratt and Silhavy, 1998). nlpC is a lipoprotein hydrolase that plays a function in 
membrane biogenesis and is involved in biofilm formation (Petersen, 2018). AI-2 synthesis 
will upregulate both motB and crl but will downregulate nlpC (DeLisa et al., 2001).  
Due to the continuous development of antibiotic resistance despite the introduction of new 
antibiotics, along with the issue on biofilm formation, the need to search for an alternative 
therapy is indispensable to maintain the human life for the next generations. In this study, the 
antibacterial and antibiofilm ability of Manuka honey was analysed; Manuka honey is a 
suggested alternative medicine to treat the antibiotic-resistant pathogens as well as a means 
to address the problem on biofilm formation.  
 
1.8 Gene Expression Analysis using Quantitative PCR (qPCR) 
 
Gene expression analysis (also called mRNA analysis) is a frequently used approach in qPCR 
technique. As a first step, researchers usually convert RNA into cDNA (reverse transcription) 
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and then use the cDNA as a template for the detection and quantification of gene expression 
product in a qPCR machine (Thermo Fisher Scientific, 2019). Gene expression is a process 
by which the information from the gene is used to synthesize a functional gene product, such 
as proteins. Yet, for non-protein coding genes, such as rRNA genes, the product is a 
housekeeping RNA (Taft et al., 2010; Livak and Schmittgen, 2001). 
qPCR is a powerful and sensitive technique for gene analysis used for the detection, 
quantification and typing of different microbial products in the clinical field, in food safety 
and in veterinary diagnostics, such as quantitative gene expression analysis, pathogen 
detection and genotyping (Kralik and Ricchi, 2017; Thermo Fisher Scientific, 2019). After 
each cycle in the qPCR, fluorescence is measured, and the intensity of the fluorescent signal 
indicates the momentary amount of amplified DNA in real time. In the first cycles, the 
amount of DNA is usually too low to be detected. The specific point at which the fluorescence 
intensity increases above the detectable level, which proportionally corresponds to the initial 
number of template DNA molecules in the sample, is termed as the quantification cycle or 
Cq (Kubista et al., 2006; Kralik and Ricchi, 2017). 
In the qPCR, the analysis of the amount of gene transcript can either be absolute 
quantification or relative quantification (Tyburski et al., 2008). In absolute quantification, 
the copy number of the template is quantified based on a standard curve prepared from serial 
dilutions of known concentration of the solution of the test sequence. In relative 
quantification, the curve is used mainly for calculating the efficiency of the reaction, and the 
result is calculated relative to a calibrator. Generally, a transcript number is given in relation 
to the quantity of what is termed the reference genes. This normalization can correct the 
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differences between the compared samples. In performing relative quantification in qPCR, 
reference genes should be prepared; these genes can be defined as an internal reaction control 
whose sequences are different from that of the target. For a gene to be nominated as a 
reference, it should meet some significant criteria; most importantly, its expression level 
should be unaffected by any experimental factors. Moreover, the gene should display 
minimal variability in its expression in tissues and under different physiological states of the 
organism (Chervoneva et al., 2010; Kozera and Rapacz, 2013). 
 
1.9 Manuka Honey and its Antibacterial Activity 
 
Manuka honey is a monofloral honey that is synthesized from the nectar of flowers of 
Manuka tree (Leptospermum scoparium) by the honeybee Apis mellifera (Alvarez-Suarez et 
al., 2014). Rating of Manuka honey is usually performed using a classification system known 
as the Unique Manuka Factor (UMF). A UMF value is directly related to methylglyoxal 
(MGO) content (Mavric et al., 2008; Johnston et al., 2018).  
Honey has generally been used as a traditional remedy to treat infections since the ancient 
times. The antibacterial activity of honey varies depending on the honey type and the source. 
The inhibitory ability of honey has been attributed to its multiple components, mostly to the 
presence of hydrogen peroxide (H2O2) (Mavric et al., 2008). Other factors that contribute to 
honey activity are the osmotic effects caused by high sugar concentration, the low pH values 
due to presence of several organic acids, the antimicrobial peptide bee defensin-1, the MGO, 
the polyphenols, and other compounds that have not yet been fully elucidated (McLoone et 
al., 2016; Olaitan et al., 2007; Mavric et al., 2008). 
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Manuka honey has considerably attracted the researcher’s attention due to its biological 
properties, mainly its antimicrobial and antioxidant abilities (Alvarez-Suarez et al., 2014). 
Manuka honey consists of carbohydrates, fatty acids, proteins, minerals and phenolic and 
flavonoid compounds. These compounds might also be found in other types of honey. 
However, some unique characteristics can be found in Manuka honey, the remarkably high 
level of MGO is an example, which is formed from dihydroxyacetone to which the 
antibacterial activity of this honey is attributed. Many recent studies demonstrated the 
antibacterial activity of honey in terms of minimum inhibitory concentration (MIC), which 
is the minimum concentration of honey required to inhibit microbial growth (Mavric et al., 
2008; Johnston et al., 2018). However, many studies attribute the antimicrobial activity of 
Manuka honey to its unique level of MGO (Adams et al., 2008; Mavric et al., 2008). Lu et 
al. tested the antibacterial activity of three types of honey: Manuka (M), Kanuka (K) and 
Manuka–Kanuka (MK) that have originated from different floral sources. They found that 
each honey displayed a different antibacterial activity and which was not related to the MGO 
or H2O2 concentrations. For example, MK1 had the lowest MGO level but showed the highest 
antibacterial activity against S. aureus, B. subtilis and E. coli when exposed to catalase (to 
remove H2O2). MK2 showed a dramatic inhibitory drop down to 16 % against B. subtilis 
when exposed to catalase. MK3 exhibited a partial inhibition against P. aeruginosa but only 
without exposure to catalase. The researchers concluded that MGO and H2O2 did not merely 
participated in bacterial growth inhibition (Lu et al., 2013; Lu et al., 2014), and the activity 
might be related to different phenols or other compounds (Paramasivan et al., 2014; 
Kwakman et al., 2001). 
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Researches on Manuka honey have investigated its antibacterial activity against several 
human pathogens, even the antibiotic-resistant ones. Manuka honey showed antibacterial 
activity against E. coli, Salmonella typhimurium, E. aerogenes, S. aureus, methicillin-
resistant S. aureus (MRSA), vancomycin-resistant Enterococci (VRE) and β-haemolytic 
streptococci (Visavadia et al., 2008; Mandal and Mandal, 2011).  
The effect of different types of Manuka honey as antibiofilm have been studied. At low 
concentrations, Manuka honey may prevent biofilm formation, which was proposed to be 
induced by a stress-response as would an antibiotic. The activity of Manuka against biofilm 
was observed in many forms: (i) reduction of biofilm formation due to the MGO and sugar 
contents of the honey and (ii) reduction of biofilm mass by killing bacterial cells inside the 
biofilm matrix. In addition, the release of planktonic cells from the biofilm matrix did not 
show any resistance to the tested honey samples (Lu et al., 2014). Another study confirmed 
that no bacterial resistance has developed after Manuka treatment. This finding might be 
attributed to the honey components’ complexity that work either individually or 
synergistically to prevent resistance against honey (Cooper et al., 2010). The safety of 
Manuka honey with UMF 20+ for consumption has been evaluated in healthy individuals; 
results showed that it has no significant allergic effect, no detrimental effect against advanced 
glycation end products that are involved in many conditions (e.g. diabetes, renal disease, 
heart disease and neurodegenerative disease) and it does not alter the homeostasis in gut 
microbiota. Thus, its safety for healthy individuals is confirmed (Wallace et al., 2010). 
This study will shed light on the ability of selected antibiotic-resistant Gram-negative 
bacteria to form biofilm in different media at specific time points, demonstrating the 
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expression of some genes related to biofilm formation at those selected time points and 
suggesting an alternative therapy, which is supported by data on gene expression, to 
overcome the current two major global issues: antibiotic resistance and biofilm formation.  
 
1.10 Research Gaps  
 
The purpose of this study is to augment the knowledge gap due to the unavailability of studies 
dealing with the characteristics of biofilm formation at different time-points, due to the 
unavailability of studies dealing with genetic characteristics during biofilm formation 
involving the E. coli CTX-M-15 strain in different media, and due to the unknown correlation 
of these characteristics with the increased prevalence of and increased ability for antibiotic 
resistance. Moreover, no study has analysed the effect of Manuka honey on the selected genes 
of this strain. 
 
1.11 Overall Aims and Objectives 
 
1) To determine the biofilm formation ability. 
2) To analyse the expression of genes that are related to biofilm formation. 
3) To determine the antibacterial effect of Manuka honey on the biofilm-related gene 
expression. 
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Chapter 2:  
Biofilm formation by antibiotic-resistant 
bacteria associated with urinary tract 
infections 
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2.1 Introduction 
 
Biofilm formation includes many steps, beginning with planktonic cell attachment to a living 
or nonliving surface. This attachment is followed by micro-colony formation, giving rise to 
three-dimensional structures that, after maturation, can detach from the surface (Jamal et al., 
2018). There are limited researches on phenotypic and genotypic characteristics of antibiotic-
resistant UTI pathogens, and most work has concentrated on the prevalence of antibiotic-
resistant UTI pathogens and prevention of antibiotic misuse (Weber et al., 1999; Erb et al., 
2007; Cai et al., 2015). This work investigates the phenotypic characteristics of selected 
antibiotic-resistant isolates of E. coli (CTX-M-15, TEM-3 and IMP-type) and K. pneumoniae 
(OXA-48, SHV-18, NDM-1 and KPC-3) with respect to their ability to form biofilms, and 
compares their characteristics to those of non-resistant strains (E. coli 12241 and K. 
pneumoniae 9633). Most UTIs are associated with biofilm formation, and the study of this 
ability is of high importance because the microorganisms in the biofilms are hard to treat 
with the current traditional antimicrobials (Niveditha et al., 2012; Soto et al., 2006; Soto et 
al., 2007). Besides, many studies showed a relation between antibiotic resistance and biofilm 
formation (Cho et al., 2018; Cepas et al., 2019).  
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2.1.1 Aims and Objectives 
 
Aim 
 
The aim of this research is to investigate the phenotypic characteristics of the selected 
antibiotic-resistant isolates E. coli (CTX-M-15, TEM-3 and IMP-type) and K. pneumoniae 
(OXA-48, SHV-18, NDM-1 and KPC-3) for their ability to form biofilms, compare their 
characteristics with the non-resistant strains (E. coli 12241 and K. pneumoniae 9633), and 
try to find through those characteristics why those strains are antibiotic-resistant. 
 
Objectives 
 
• to confirm the species and the type of antibiotic-resistance of the selected strains 
• to determine the biofilm densities of the growing cells in the different media at the four 
time-points via measuring the absorbency at 570 nm. 
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2.2 Materials and methods 
 
2.2.1 Buffers, solutions and reagents 
 
Table 2.1 The reagents and solutions used in this study and their preparations. 
Reagent/Solution Preparation  
Crystal violet for gram 
staining 
For 100 mL, 0.5 g crystal violet (Acros Organics), 25 mL methylated 
spirit (Fisher Scientific), 75 mL distilled water 
Iodine solution for gram 
staining 
For 500 mL, 5 g iodine (Fisher Scientific), 10 g KI (Fisher Scientific),  
500 mL distilled water  
Safranine  For 100 mL, 0.5 g safranine (Fisher Scientific), 100 mL distilled water 
Crystal violet for biofilm 
staining 
For 100 mL, 2 g crystal violet (Acros Organics), 25 mL methylated  
spirit (Fisher Scientific), 75 mL distilled water 
Phosphate buffered saline 
(PBS) 
For 100 mL, 1 tablet of PBS (Thermo Fisher Scientific) was dissolved 
in 100 mL distilled water at a pH of 7.3-7.5 followed by autoclave at 
121°C for 15 min 
Agarose gel electrophoresis For 1 % agarose, 1 g of UltraPureTM Agarose (Thermo Fisher 
Scientific, Catalogue number: 16500500) was dissolved in 100 mL of 
SYBR® Safe DNA gel stain in 1X TAE buffer (Thermo Fisher 
Scientific, Catalogue number: S33112) 
GeneRuler 50 bp DNA 
Ladder 
Ready-to-use (Thermo Fisher Scientific, Catalogue number: SM0373) 
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2.2.2 Growth media 
 
Table 2.2 The different types of growth media used in this study and their preparations. 
Media Preparation 
Nutrient agar (Oxoid) 28 g in 1000 mL distilled water, autoclaved at 121°C for 15 min 
Mueller-Hinton agar  
(Mast group)  
36 g in 1000 mL distilled water, autoclaved at 121°C for 15 min 
Nutrient broth (Oxoid) 13 g in 1000 mL distilled water, autoclaved at 121°C for 15 min 
Luria-Bertani 
(Invitrogen) 
20 g in 1000 mL distilled water, autoclaved at 121°C for 15 min 
AB medium 
A (5X): 2 g (NH4)2SO4 (Sigma-Aldrich), 6 g Na2HPO4 (Fisher 
Scientific), 3 g KH2PO4 (Sigma-Aldrich), 3 g NaCl (Fisher Scientific), 
dissolved in 200 mL H2O and autoclaved 
B (1X): 1 mL sterile 0.1 M CaCl2 (Sigma-Aldrich), 1 mL sterile 1 M 
MgCl2 (Sigma-Aldrich), 1 mL sterile 0.003 M FeCl3 (Sigma-Aldrich), 
797 mL sterile H2O. All B salt solutions were autoclaved separately, 
then added to the H2O for a final volume of 800 mL.  
200 mL of A was added to 800 mL of B for a final volume of 1 L. 
Sterile 0.2 % glucose (Fisher Scientific) as a carbon source, and 10 
µg/mL sterile thiamine (Fisher Scientific) were added to the final 1000 
mL volume of AB medium. 
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2.2.3 Bacterial strains and growth conditions 
 
All bacterial strains used in this study were obtained from Public Health England (PHE). 
Nutrient agar was used to culture the bacterial strains (Table 2.2) in a static incubator at 37℃. 
Bacterial colonies were obtained from the overnight growths, placed into Protect bead tubes 
(Microorganism Preservation System) according to the manufacturer’s instructions, and 
stored at -80°C until use. All strains listed in Table 2.3 were antibiotic-resistant except K. 
pneumoniae 9633 and E. coli 12241, with non-resistant strains used for comparison.  
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Table 2.3 The bacterial strains used in this study, along with their characteristics. Strains were ordered directly 
from NCTC and later confirmed in this study. 
Organism Strain name Characteristics Reference 
K. pneumoniae  NCTC 13442 Sequence type 353 with OXA-48  (Dimou et al., 2012) 
K. pneumoniae  NCTC 13368  SHV-18 (ATCC 700603)  (Culture collections, 
2013a) 
K. pneumoniae NCTC 13443  New Delhi Metallo-β-lactamase (NDM-1)  (Culture collections, 
2013a) 
K. pneumoniae NCTC 13438  Member of the International ST258  
clone that produces KPC-3 carbapenemase 
(Woodford et al., 
2008) 
K. pneumoniae NCTC 9633 (ATCC 13883) Type strain / P. R. Edwards, 
CDC Atlanta in 1955 / Capsular serotype 3  
(Culture collections, 
2013c) 
E. coli  NCTC 13353  Strain EO 487. CTX-M-15 ESBL producer. 
Control strain for group 1 blaCTX-M multiplex 
PCR assays 
 (Woodford et al., 
2004) 
E. coli  NCTC 13351   TEM-3 ESBL. Transconjugant of strain 
isolated in 1985 in Clermont-Ferrand  
 (Sirot et al., 1987) 
E. coli  NCTC 13476  IMP-type (unsequenced)  (Collections, 2013a) 
E. coli  NCTC 12241 Clinical isolate/control organism for 
sensitivity testing of bacteria to different 
antibiotics  
 (Collections, 2013b) 
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2.2.4 Gram staining 
 
Gram staining was performed to confirm that the tested strains were Gram-negatives (Willey, 
2005).  
 
2.2.4.1 Making and fixing samples 
 
Slides were labelled on the frosted panel, and a small drop of distilled water was placed on 
the transparent area of the slide. A smear of culture was picked using a sterilized loop (flamed 
and cooled) and mixed to emulsify the bacteria, then spread to create a thin smear and dried 
by gently passing over a flame. 
 
2.2.4.2 Staining with Gram stain 
 
Crystal violet was added to the fixed smear for 30 seconds and then washed with distilled 
water and drained. Slides were then covered with iodine solution for 60 seconds and again 
washed with distilled water. The smear was subsequently decolorized by dipping in 95 % 
alcohol for 30 seconds and washed with distilled water. Finally, safranin was added as a 
counterstain for 60 seconds and washed with distilled water. Slides were allowed to dry 
before examination under a light microscope.  
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2.2.5 API 20E test 
 
API 20E is an Enterobacteriaceae and other Gram-negative non-fastidious rods standardized 
identification system that utilizes 21 miniaturized biochemical tests and a database. The test 
consists of 20 microtubes containing dehydrated substrates. API 20E testing was performed 
according to the manufacturer’s instructions. Briefly, microtubes were inoculated with the 
tested bacteria in suspension and then incubated at 37°C for 18 to 24 h. Color changes occur 
during incubation due to bacterial metabolism. These changes can be observed directly or 
after the addition of specific reagents provided in the kit. Reaction results are read according 
to the reading table, and identified by matching to the Analytical Profile Index or using 
included identification software (API 20E, 2010).  
Strains were cultured on nutrient agar plates and incubated overnight at 37℃ in a static 
incubator. One colony was picked from each plate and inoculated into 10 mL of sterilized 
distilled water with shaking to ensure mixing. Using a sterile Pasteur pipette, each 
compartment of the API 20E strip was filled to the limit established by the manufacturer. 
Certain compartments contained oil to provide anaerobic conditions. Finally, strips were 
placed onto wetted trays, covered with lids, and incubated at 37°C for 24 h. After incubation, 
results were documented and interpreted using https://apiweb.biomerieux.com. Interpretation 
of the results is facilitated by a seven-digit number representing the Profile Recognition 
Number. The Profile Register Index associates the species with the given number (Janin and 
Pierre, 1976). 
An oxidase test was performed independently as part of the detection process. Several 
colonies from a single culture grown on a nutrient agar plate were wiped onto the paper zone 
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of the diagnostic strip containing N, N-dimethyl-p-phenylenediamine. Results were read and 
recorded after one min. A dark blue or black spot indicated a positive result; no color change 
indicated a negative result (Collins et al., 2004). 
 
2.2.6 Antibiotic sensitivity testing using double-disk diffusion  
 
Double-disk diffusion tests were performed according to the manufacturer’s instructions 
(Mast group), and the two sets used in this assay were D67C and D70C. The presence of 
ESBL or Carbapenemases was confirmed by comparing the zone sizes between the antibiotic 
and antibiotic plus inhibitor. 
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) standardized 
disc susceptibility testing method was utilized for the preparation of the inoculums to 
generate semi-confluent growth of bacterial colonies after overnight incubation (Fig 2.1) 
(BSAC, 2015). Subsequently, these inoculums were compared to the 0.5 McFarland 
standard.  
The 0.5 McFarland standard was made by mixing 0.5 mL of 0.048 M BaCl2 with 99.5 mL of 
0.18 M H2SO4 and stir constantly. Absorbance was measured at 625 nm. Absorbance ranges 
were adjusted via dilution to fall between 0.08 and 0.13. Standards were equally delivered 
into screw-cap tubes of the same volume and size as those used for broth cultures, stored 
away from light at room temperature. 
After incubation, strains that were grown on nutrient broth were streaked onto Mueller-
Hinton agar (MHA) and incubated with the related disks sets at 37°C for 18 to 20 h. two 
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types of disks were used in this study; D67C and D70C. D67C and D70C were used to detect 
the presence of ESBLs and Carbapenemases, respectively. ESBLs were defined as positive 
when a zone of diameter difference at least 5 mm for D67C disks (Fig 2.2). For D70C disks, 
a zone of diameter difference of at least 4 mm was used with disk C, and at least 5 mm with 
disk B, compared to disk A (Fig 2.3). Tests for each strain were done in triplicate and results 
are represented as the mean of three replicates of the zone of inhibition diameter.  
 
 
 
 
 
 
 
Fig 2.1 Acceptable range of inoculums density for Gram-negative rod bacteria (BSAC, 2015). 
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Fig 2.2 D67C (CAZ30, ceftazidime 30 µg; CAZ30/CLAV10, Ceftazidime 30 μg + Clavulanic acid 10 μg; 
CTX30, Cefotaxime 30μg; CTX30/CLAV10, Cefotaxime 30μg + Clavulanic acid 10μg; CPD10, Cefpodoxime 
30μg, CPD10/CLAV1, Cefpodoxime 30μg + Clavulanic acid 10μg) confirmation of production of ESBL in 
Enterobacteriaceae that has no chromosomal de-repressed or inducible ampC. ESBL Positive if Z2-Z1 ≥ 5mm 
and/or Z4-Z3 ≥ 5mm and/or Z6-Z5 ≥ 5mm. CAZ, ceftazidime; CLAV, clavulanic acid; CTX, cefotaxime; CPD, 
cefpodoxime (Mast, 2015). 
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Fig 2.3 D70C cartridge A, carbapenem 10 µg discs; cartridge B, carbapenem 10 µg + MBL (Metallo-β-
lactamase) inhibitor discs; cartridge C, carbapenem 10 µg KPC inhibitor discs; cartridge D, carbapenem 10 µg 
+ AmpC inhibitor discs. Detection of production of carbapenemase enzyme in Enterobacteriaceae: If disc B 
shows a zone difference ≥ 5 mm more than disc A, the organism has MβL activity. If disc C shows a zone 
difference ≥ 4 mm more than disc A, the organism has KPC activity. If discs C and D show zone differences of 
≥ 4 mm and ≥ 5 mm, respectively, compared to disc A, the organism has AmpC activity coupled with porin 
loss (Mast, 2015). 
 
2.2.7 Genotypic confirmation of antibiotic-resistant gene using PCR 
 
Polymerase chain reactions were conducted with a thermal cycler (Garrec et al., 2011). A 
suitable set of primers were designed to target the resistance gene specific to the given strain 
(Table 2.4) using gene sequences obtained from the NCBI website 
(https://www.ncbi.nlm.nih.gov/, National Center for Biotechnology Information, Bethesda, 
USA). Gene sequences were copied and pasted into the primer request tool on the IDT 
website (https://eu.idtdna.com/, Integrated DNA Technologies). Three fresh colonies were 
picked from each strain after overnight growth on agar medium. Colonies were inoculated 
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into 50 µl of sterilized distilled water in an Eppendorf tube, boiled for 10 min in a dry bath, 
and centrifuged for 1 min. One µl of the supernatant was used as a template for the PCR 
reaction. PCR amplification was performed in a 50 µl volume for each sample in accordance 
with the GoTaq® DNA polymerase manufacturer instructions (Table 2.5), and the PCR 
conditions were adjusted as described in Table 2.6. 
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Table 2.4 Primers used in this study. Primers were designed using the OligoAnalyzer 3.1 (Integrated DNA 
Technologies Inc, Illinois, USA). Primers were then checked for specificity by the BLAST software (National 
Center for Biotechnology Information, Bethesda, USA). All PCR products were run on a 1 % agarose gel for 
90 mins at 60 Volts. A GeneRuler 50 bp DNA Ladder was used for comparison. 
Primer  Sequence (5ʹ-3ʹ) Target 
 Amplicon 
size (bp) 
 
Reference 
OXA-48F   CGGAATGCCTGCGGTAGCA blaOXA-48 713 This study 
OXA-48R  TGATGGCTTGGCGCAGC      
KPC-3F  GCGGAACCATTCGCTAAAC blaKPC-3  864 This study 
KPC-3R  GACAGTGGTTGGTAATCCATGC      
NDM-1F  AATGGAACTGGCGACCAAC blaNDM-1  322 This study 
NDM-1R  TCGACAACGCATTGGCATAA      
IMP-6F  GCAGCATTGCTACCGCAG blaIMP-type  657 This study 
IMP-6R  CCGCCTGCTCTAATGTAAGT      
CTX-M-1-F  AAAAATCACTGCGCCAGTTC 
blaCTX-M-
15 415 
(Al-
Mayahie, 
2013) 
CTX-M-1-R  AGCTTATTCATCGCCACGTT      
SHV-18F  CTCAAGGATGTATTGTGGTTATGC blaSHV-18  912 This study 
SHV-18R  CGAGCCGGATAACGCGCGCG      
TEM-1F  GTAAAAGATCCTGAAGATCAG blaTEM-3  768 This study 
TEM-1R  CCAATGCTTAATCAGTGAGG      
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Table 2.5 The reagents used in PCR amplification reaction and their volumes. 
Component Final volume 
5X Green GoTaq® Flexi Buffer 10 µl 
MgCl2 5 µl 
PCR Nucleotide Mix 1 µl 
Upstream primer 0.5 µl 
Downstream primer 0.5 µl 
GoTaq® Flexi DNA Polymerase 0.25 µl 
Template DNA 1 µl 
Nuclease-Free Water up to 50 µl 
 
 
Table 2.6 Cycling parameters for PCR reaction.  
Step  Time/cycles Temperature 
Initial activation step  2 min  98°C 
 Denaturation  10 s  98°C 
 Annealing  1 min  50°C 
 Extension  30 sec/kb  72°C 
Final extension  5 min  72°C 
 Number of cycles  40 cycles  
 End of PCR cycling  Indefinite  4°C 
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2.2.7.1 Agarose gel electrophoresis 
 
PCR products were run on 1 % agarose gel. 1 g of agarose was dissolved into 100 mL of 1X 
TAE buffer containing SYBR® Safe dye, heated in a microwave, and poured into a casting 
tray. A well comb was fixed and allowed to cool and solidify. The comb was removed, and 
the unit was enclosed in a gel box. TAE buffer was poured into the gel box to cover the upper 
area of the gel. Samples were prepared, and 5 µl of each were loaded into the gel wells. The 
first and last wells were inoculated with 5 µl of DNA ladder for sizing. All units were 
covered, and the voltage was adjusted to 5 V/cm for 90 mins. Fragments were visualized 
using a Gel DocTM EZ System gel imaging instrument. 
 
2.2.7.2 Sequencing for genotypic confirmation  
 
PCR products (50 µl) along with 100 µl of their DNA primer pairs were sent to Macrogen 
Europe to confirm the DNA sequences of the genes from each antibiotic-resistant strain. 
Sequencing results data were delivered online, and the DNA sequences were checked for 
compatibility using the NCBI BLAST tool (Nucleotide BLAST).  
 
2.2.8 Biofilm formation assay (tissue culture plate assay) 
 
A tissue culture plate (TCP) assay was conducted according to the protocols set out by Fattahi 
et al., (2015), Lee et al., (2011), and Beehan et al. (2015), with modifications. Six-well tissue 
culture plates (TCP, Techno Plastic Products) were used in this assay. Three types of growth 
media were provided, namely LB broth, AB medium, and NB.  
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A loopful of bacterial colonies were inoculated into 5 mL of LB and NB and incubated 
overnight at 37°C with either static incubation or shaking at 70 rpm. After incubation, 
cultures were diluted to an OD600 of 0.01 in 5 mL in each well. Colonies grown in LB were 
inoculated into TCP containing LB and AB, while those grown in NB were inoculated into 
TCP containing NB. Each strain was cultured in triplicate for each biological replicate. All 
inoculated TCPs were incubated at 37°C in a static incubator (for cultures previously 
incubated in stasis) or shaker incubator at 70 rpm (for cultures previously incubated with 
shaking) and evaluated at 6, 12, 24, or 48 h. After incubation, the broth was removed, and 
wells were washed three times using sterile PBS. Bacteria in wells were fixed with 5 mL of 
99 % methanol for 15 min. The methanol was discarded, and wells were dried in an inverted 
position for 30 min at room temperature.  5 mL of 2 % crystal violet were used to stain each 
well and for 5 min at room temperature, after which excess stain was rinsed with sterilized 
distilled water. The remaining dye was re-solubilized with 4 mL of 33 % glacial acetic acid 
and allowed to sit at room temperature for 30 min. Finally, optical densities at 570 nm were 
measured for each well using a Helios Gamma UV-Vis spectrophotometer and recorded. 
Mean values of three technical replicates (which represent one biological replicate) were 
obtained, then the mean value of the three biological replicates was calculated. 
 
2.2.9 Statistical analysis 
 
Since data are normally distributed, results were assessed with one-way ANOVA to evaluate 
the significance of differences in biofilm formation among the tested strains. Microsoft Excel 
365 and Prism 6 version 6.01 were used to perform statistical calculations. For both tests, a 
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p-value of less than 0.01 was considered statistically significant. Comparisons of biofilm 
density values were evaluated among the four growth stages. A descriptive study was 
conducted by classifying all isolates into categories according to their highest OD570 values, 
wherein 0 indicated no adherence, 0.2 indicated weak adherence, 0.2 to 0.4 indicated 
moderate adherence, and above 0.4 indicated strong adherence. Statistical analysis was 
performed for three technical replicates of each of three biological replicates. 
 
 
2.3 Results 
 
2.3.1 Gram staining 
 
Gram staining was performed to verify the strains used in this study. All test strains showed 
a pink color and were thereby confirmed to be Gram-negative (Fig 2.4). 
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Fig 2.4 Gram-staining of test strains showing all were Gram-negative. (a) E. coli IMP-type; (b) K. pneumoniae OXA-48; (c) E. coli CTX-M-15; (d) E. coli 
TEM-3; (e) K. pneumoniae SHV-18; (f) K. pneumoniae KPC-3; (g) K. pneumoniae NDM-1; (h) K. pneumoniae 9633; (i) E. coli 12241. Magnification 100.
(a) (b) 
(e) (f) 
(c) 
(d) 
(g) (h) (i) 
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2.3.2 API 20E 
 
API 20E is a standardized identification system for Enterobacteriaceae and other non-
fastidious, Gram-negative rods. Table 2.7 shows the API 20E and oxidase test results, which 
were interpreted using API identification software. Strains were confirmed based on their 
Profile Recognition Numbers.  
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Table 2.7 API 20E biochemical tests results; (+), positive; (-), negative. Abbreviations represent tests for the presence of specific enzymes or fermentation 
of specific sugars.  
Strain 
O
N
P
G
 
A
D
H
 
L
D
C
 
O
D
C
 
C
IT
 
H
2
S
 
U
R
E
 
T
D
A
 
IN
D
 
V
P
 
G
E
L
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L
U
 
M
A
N
 
IN
O
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O
R
 
R
H
A
 
S
A
C
 
M
E
L
 
A
M
Y
 
A
R
A
 
O
X
 
K. pneumoniae 
OXA-48 
 + -  +  -  +  -  +  -  -  +  -  +  +  +  +  +  +  +  +  +  - 
K. pneumoniae 
SHV-18 
 + -  +  -  +  -  +  -  -  +  -  +  +  +  +  +  +  +  +  +  - 
K. pneumoniae 
NDM-1 
 + - +  -  +  -  +  -  -  +  -  +  +  +  +  +  +  +  +  +  - 
K. pneumoniae 
KPC-3 
 + - +  -  +  -  +  -  -  +  -  +  +  +  +  +  +  +  +  +  - 
K. pneumoniae 
9633 
 + - +  -  +  -  +  -  -  -  -  +  +  +  +  +  +  +  +  +  - 
E. coli IMP-type  +  -  +  +  -  -  - +   -  - -  +   +  -  +  +  +  +  -  + - 
E. coli CTX-M-
15 
 +  -  +  +  -  -  -  +  -  -  -  +  +  -  +  +  +  +  -  + - 
E. coli TEM-3  +  -  +  -  -  -  -  +  -  -  -  +  +  -  +  +  -  +  -  + - 
E. coli 12241  +  -  +  -  -  -  -  +  -  -  -  +  + -   +  +  -  +  -  + - 
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Results are shown as percentages representing the probability of being the expected species 
in the specified test. These values were 97.3 % for K. pneumoniae OXA-48, SHV-18, NDM-
1, and KPC-3, 94.8 % for K. pneumoniae 9633, 98.4 % for E. coli IMP-type and CTX-M-15, 
and 89.7 % for E. coli TEM-3 and 12241. 
 
2.3.3 Antibiotic sensitivity tests  
 
The mean values of each test, performed in triplicate, were recorded on a table and interpreted 
using MAST standard instructions (Tables 2.8 and 2.9). As shown in Table 2.8, K. 
pneumoniae SHV-18, E. coli CTX-M-15, and E. coli TEM-3 showed a zone of diameter 
difference of at least 5 mm between the antibiotic and its inhibitor, indicating they were 
ESBL. 
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Table 2.8 D67C ESBL set for confirmation of production of ESBL in Enterobacteriaceae that has no 
chromosomal de-repressed or inducible AmpC. K. pneumoniae OXA-48, NDM-1, KPC-3, and E. coli IMP-
type are a special class of antibiotic-resistant organisms that produce carbapenemase, as shown by negative 
test results (non-ESBL). (CV: clavulanic acid) 
D67C ESBL Set  
strain CPD 
CPD 
CV CTX 
CTX 
CV CAZ 
CAZ 
CV 
interpretation 
K. pneumoniae OXA-48 
(resistant) 
17.7 17.7 20.7 20.7 22.3 22.7 
Non-ESBL 
K. pneumoniae SHV-18 8.3 19.3 15.3 20.3 9.0 21.0 ESBL 
K. pneumoniae NDM-1 (resistant) 7.0 7.3 7.3 6.7 6.7 6.7 Non-ESBL 
K. pneumoniae KPC-3 (resistant) 6.0 6.0 9.3 10.3 6.3 6.0 Non-ESBL 
K. pneumoniae 9633 (non-
resistant) 
25.0 25.0 28.7 28.7 23.3 22.3 
Non-ESBL 
E. coli IMP-type (resistant) 6.0 6.0 7.7 7.7 6.0 6.0 Non-ESBL 
E. coli CTX-M-15 6.0 17.3 6.0 15.0 11.0 23.7 ESBL 
E. coli TEM-3 6.0 21.7 13.0 23.0 10.0 26.7 ESBL 
E. coli 12241 (non-resistant) 22.3 23.0 29.3 30.3 27.0 27.0 Non-ESBL 
 
In tests with the D70C carbapenemase detection disk (Table 2.9), K. pneumoniae NDM-1 
and E. coli IMP-type were confirmed as MBLs by showing a zone of diameter difference of 
greater than 5 mm between disk A and disk B, and K. pneumoniae KPC-3 was confirmed as 
having KPC activity by showing a zone of diameter difference greater than 4 mm between 
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disk C and disk B. K. pneumoniae OXA-48 did not show any carbapenemase activity; 
however, this assay only detects isolates with MBL, KPC and/or AmpC activity. As such, 
additional testing for confirmation was required. 
 
Table 2.9 D70C carbapenemase detection disk set for the detection of carbapenemase enzyme production in 
Enterobacteriaceae. This test detects MBL and KPC-type carbapenemase.  
D70C Carbapenemase  
strain D70A D70B D70C D70D Interpretation 
K. pneumoniae OXA-48 (resistant) 
18.7 17.7 17.7 18.7 
Molecular 
testing required 
K. pneumoniae SHV-18 (resistant) 26.7 25.7 25.7 26.7 -ve 
K. pneumoniae NDM-1 7.0 14.3 7.0 7.3 MBL activity 
K. pneumoniae KPC-3 6.0 7.7 13.3 9.0 KPC activity 
K. pneumoniae 9633 (non-resistant) 29.3 27.0 27.3 27.7 -ve 
E. coli IMP-type 13.0 22.3 14.7 16.0 MBL activity 
E. coli CTX-M-15 (resistant) 27.3 26.3 26.7 27.0 -ve 
E. coli TEM-3 (resistant) 30.7 29.3 30.3 31.3 -ve 
E. coli 12241 (non-resistant) 28.3 27.7 27.3 28.3 -ve 
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2.3.4 Genotypic confirmation of antibiotic-resistant gene with PCR 
 
Figure 2.5 shows the gel electrophoresis results for the tested strains. The resulting fragments 
were compared with their expected sizes, and all were roughly the same as expected, 
indicating that all our test strains were harbouring the antibiotic resistance gene related to 
their strains. The negative controls (-ve) had no template added (no bacterial DNA). 
Fig 2.5 PCR products of the seven antibiotic resistance gene primers run on 1 % agarose in TAE buffer. The 
bands of DNA fragment from the left; 1: 713 bp for the OXA-48, 2: 912 bp for SHV-18, 3: 322 bp for NDM-
1, 4: 864 bp for KPC-3, 5: 657 bp for IMP-type, 6: 370 bp for CTX-M- 15, and 7: 768 bp for TEM-3. Control 
sequences; 8: -ve OXA-48, 9: -ve SHV-18, 10: -ve NDM-1, 11: -ve KPC-3, 12: -ve IMP-type, 13: -ve CTX-M- 
15, and 14: -ve TEM-3. The gel was run at 5 V/cm. 
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2.3.5 Genotypic confirmation of antibiotic-resistant gene sequence 
 
PCR products of the antibiotic resistance sequences for each of the tested strains were sent 
for sequencing for further confirmation that the tested antibiotic-resistant isolates carried the 
expected antibiotic resistance gene sequence. Results of sequencing data were obtained 
online, and the NCBI BLAST tool was used to assess their percentage similarities with 
corresponding sequences. Percentages of similarity for each sequence are shown in Table 
2.10. 
 
Table 2.10 Sequence similarity for antibiotic resistance genes. 
Strain % similarity 
K. pneumoniae OXA-48 99.26  
K. pneumoniae SHV-18 97.70  
K. pneumoniae NDM-1 99.13  
K. pneumoniae KPC-3 96.51  
E. coli IMP-type 98.51  
E. coli CTX-M-15 99.72  
E. coli TEM-3 99.75  
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2.3.6 Biofilm formation assay 
 
OD570 values which represent biofilm densities were recorded and plotted as bar charts (Fig. 
2.6 – 2.11).  
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Fig 2.6 Biofilm formation of E. coli strains CTX-M-15, IMP-type, TEM-3, and 12241 grown in AB broth with shaking and static incubation at 6, 12, 24, 
and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent the standard 
deviation of the mean. 
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Fig 2.7 Biofilm formation of E. coli strains CTX-M-15, IMP-type, TEM-3, and 12241 grown in NB broth with shaking and static incubation at 6, 12, 24, 
and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent the standard 
deviation of the mean. 
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Fig 2.8 Biofilm formation of E. coli strains CTX-M-15, IMP-type, TEM-3, and 12241 grown in LB broth with shaking and static incubation at 6, 12, 24, 
and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent the standard 
deviation of the mean. 
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Fig 2.9 Biofilm formation of K. pneumoniae strains KPC-3, NDM-1, SHV-18, OXA-48, and 9633 grown in AB broth with shaking and static incubation at 
6, 12, 24, and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent 
the standard deviation of the mean. 
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Fig 2.10 Biofilm formation of K. pneumoniae strains KPC-3, NDM-1, SHV-18, OXA-48, and 9633 grown in NB broth with shaking and static incubation 
at 6, 12, 24, and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent 
the standard deviation of the mean. 
 
 
 
 
S h a k e r  N B
O
D
 5
7
0
 n
m
9
6
3
3
O
X
A
-4
8
S
H
V
-1
8
N
D
M
-1
K
P
C
-3
0 .0
0 .2
0 .4
0 .6
0 .8
S ta tic  N B
O
D
 5
7
0
 n
m
9
6
3
3
O
X
A
-4
8
S
H
V
-1
8
N
D
M
-1
K
P
C
-3
0 .0
0 .2
0 .4
0 .6
0 .8
104 
 
 
 
 
 
 
 
 
 
Fig 2.11 Biofilm formation of K. pneumoniae strains KPC-3, NDM-1, SHV-18, OXA-48, and 9633 grown in LB broth with shaking and static incubation at 
6, 12, 24, and 48 h. The experiment was done in three biological replicates, and data represent the means of those biological replicates. Error bars represent 
the standard deviation of the mean. 
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For E. coli grown in AB medium (Fig 2.6), the standard patterns of biofilm formation stages 
in all the tested strains (except E. coli CTX-M-15) emulate the selected time-points illustrated 
in the virtual graph in Fig 2.12 for both static and shaking incubations. Comparing the biofilm 
density, there was noticeably more biofilm density in static incubation compared with 
shaking incubation. 
Fig 2.12 Virtual bar chart represents a presumed ideal result for what could be obtained in biofilm measurements 
if the selected time-points match the sequential biofilm formation stages of the selected tested strains. This bar 
chart shows the time-points presented by hours (6, 12, 24, and 48) and the description of the events on the 
specified time-point (Stoodley et al, 2002). 
 
In Fig 2.7, the biofilm formation cycle started early for all E. coli strains when grown on NB, 
as the graph shows a decrease in density after 12 h in static and after 6 h in shaking (except 
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E. coli CTX-M-15) incubation that could suggest that the attachment stage somehow started 
early, before the 6 h of incubation. 
In LB media (Fig 2.8), the biofilm initiation started early for both static and shaking 
incubation. There was a different pattern of biofilm formation as shown in both graphs. In 
shaking incubation, all strains (except E. coli CTX-M-15) showed undulating bars. In static 
incubation, the graph showed bars decreasing in length, which might also indicate an early 
biofilm formation stage but with higher density than in shaking (except E. coli CTX-M-15). 
For K. pneumoniae strains grown in AB broth (Fig 2.9), both bar charts show a clear biofilm 
stages emulating the virtual bar chart, regardless of the density values of biofilm compared 
to both stages, apart from OXA-48 (in shaking incubation) and SHV-18 (in static and shaking 
incubations), which showed undulating bars that in turn might indicate two biofilm cycles.  
In NB (Fig 2.10), all K. pneumoniae strains showed undulating bars when grown under 
shaking conditions, which might also indicate two biofilm cycles. While in static incubation, 
they showed the standard pattern of biofilm stages, regardless of the biofilm level difference 
between the resistant strains and the non-resistant control. 
 For LB broth (Fig 2.11) in shaking incubations, strains showed an early biofilm formation 
initiation stage as can be seen from the high biofilm level at 6 h, decreasing afterwards. There 
was an increase in biofilm level at 48 h, which might indicate a second biofilm cycle as there 
is a 24 h difference between 24 h and 48 h. On the other hand, under static conditions, both 
NDM-1 and KPC-3 showed the same standard pattern of biofilm stages as the control strains, 
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while both OXA-48 and SHV-18 showed the undulating bars which might indicate two 
biofilm cycles as well. 
One-way ANOVA was used to detect whether there is any significant difference in biofilm 
density values measured in OD570 among the selected time-points for each strain for all media 
and for both static and shaking incubations. Results are presented in Appendix II (Tables 2.I 
through 2.XII). 
Tested strains were classified by OD570 value in accordance with results from a previous 
study by Beehan et al. (2015) (section 2.2.9). According to Table 2.11, an OD570 value above 
0.2 in any test was considered an adherence indication for biofilm formation. 
 
 
 
 
 
 
 
 
 
 
108 
 
Table 2.11 Mean value for each strain’s biofilm at the maturation stage when it reached the maximum value 
by means of OD570 value during the four recorded time-points (6, 12, 24, and 48 h). Green colors represent the 
weak adherence (OD570 value < 0.2), yellow colors represent the moderate adherence (OD570 value 0.2 - 0.4), 
and pink colors represent the strong adherence (OD570 value >0.4). 
Strain 
AB LB NB 
Shaker Static Shaker Static Shaker Static 
K. pneumoniae OXA-48 0.52 0.37 0.44 0.35 0.41 0.69 
K. pneumoniae SHV-18 0.37 0.20 0.41 0.56 0.64 0.74 
K. pneumoniae NDM-1 0.70 0.36 0.58 0.31 0.63 0.63 
K. pneumoniae KPC-3 0.71 0.41 0.62 0.50 0.67 0.88 
K. pneumoniae 9633 0.07 0.37 0.10 0.06 0.11 0.10 
E. coli IMP-type 0.08 0.20 0.22 0.48 0.16 0.19 
E. coli CTX-M-15 0.11 0.67 0.61 0.61 0.32 0.35 
E. coli TEM-3 0.09 0.64 0.26 0.51 0.09 0.34 
E. coli 12241 0.06 0.131 0.17 0.345 0.073 0.12 
 
 
 
 
 
 
 
109 
 
2.4 Discussion 
 
This chapter focuses on the ability of selected antibiotic-resistant strains to form biofilms. 
These strains comprise the main class of antibiotic-resistant organisms characterized by PHE 
and have been associated with urinary tract infections (UTIs) (Public Health England, 2018). 
Strains used in our study are listed by WHO as priority group 1 pathogens, tiered as “critical” 
in need for research and development of new antibiotics. These pathogens are grouped by 
species and type of resistance (Tacconelli et al., 2017). The selected strains in this study 
belong to the family of Enterobacteriaceae, which includes K. pneumoniae and E. coli.  
Results revealed that timing of biofilm stages would not be the same for all strains due to 
phenotypic and genotypic variations among them. This important feature must be considered 
when selecting the proper treatment for biofilm infections, as antimicrobial tolerance 
increased proportionally with biofilm maturation (Ciofu et al., 2017). Results also showed 
the adaptability of these strains to the different experimental conditions, and that might be 
one of the reasons these strains are highly successful in causing UTIs. 
Analyses showed that all antibiotic-resistant E. coli strains were high biofilm formers when 
grown in LB under static incubation. Antibiotic-resistant K. pneumoniae strains were, in 
general, a high biofilm former, particularly in NB and shaker LB. This suggests that those 
media are preferred by the tested strains. These results suggest that the antimicrobial 
tolerance will increase under such conditions, as the biofilm thickness controls the 
antimicrobial penetration (Stewart, 1996). This can lead to an increased tolerance by the 
microorganisms and the subsequent development of antimicrobial resistance (Levin-Reisman 
et al., 2017).  
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Results showed the most significant variation was associated with E. coli CTX-M-15, as it 
conferred the highest biofilm density values in all the growth media (Table 2.11). Besides, 
E. coli CTX-M-15 which did not follow the same pattern for other E. coli strains used in this 
study, as it showed different patterns of biofilm formation stages (Fig 2.6-2.8). These findings 
could explain why the CTX-M family is the most prevalent type of ESBL in the UK (Lupo 
et al., 2013), and CTX-M-15 is one of the most prevalent variants among UTIs in the UK 
(Cantón et al., 2012; Reid, 2018). It is also expected that those findings are related to the 
increased resistance of these strains demonstrated in previous studies.  
The process and parameters involved in biofilm formation remain poorly understood (Rabin 
et al. 2015). Although extensive research has been carried out on biofilms, limited studies 
have compared biofilm formation stages produced by antibiotic-resistant E. coli and K. 
pneumoniae strains associated with UTIs among different types of growth media, static 
versus shaking incubation, and different time-points. In this study, all the above were 
compared. 
Gram-staining and API 20E were performed to confirm the species of the tested strains, while 
double-disk diffusion tests D67C and D70C were performed to confirm whether the tested 
strains are antibiotic-resistant and the type of resistance. D70C was designed to detect 
Carbapenemases with Metallo-ß-lactamase and KPC activity and not oxacillinase (OXA) 
according to the manufacturer. Accordingly, molecular testing was required to detect the 
presence of the OXA-48 resistant gene, and to further confirm the presence of resistance 
genes in the other tested strains. 
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Gel electrophoresis of PCR products for the resistance genes confirmed the type of resistance 
by matching the expected fragments’ sizes with the resultant fragments that appeared on the 
gel. Moreover, sequencing the resultant fragments added more confirmation. The NCBI 
BLAST tool results of similarity showed a percentage ranged from 96.51 % to 99.75 % of 
matches, which represents a high and accepted values of matches. 
OD570 values representing biofilm densities showed variable quantities of absorbency for 
each of the tested strain in every time-point of growth, in all the growth media, under static 
and shaking incubations as shown in Figures 2.6 through 2.11.  
It was presumed that the four bars arrangement (that represents the absorbency value 
corresponding to biofilm densities of the selected four time-points) in the bar chart would 
look like a bell-shape, as presented in the virtual bar chart above. Those four time-points 
were selected according to a previous study done by Atshan et al. (2013), who studied the 
biofilm formation ability of Staphylococcus aureus at four time-points of growth (6, 12, 24, 
and 48 h), which represented the biofilm development stages according to that study.  
In general, the majority of the results of this work did not follow the presumed bars sequence 
in the above bar chart. Instead, there was a variability in each condition depending on the 
strain type, type of media, and static and shaking incubation (Fig 2.6 through 2.11).  
Growth medium composition affects biofilm formation (Hancock et al., 2011; Reisner et al., 
2006), and the present study tested the effect of three different media types on biofilm 
formation, namely nutrient broth (NB), Luria-Bertani (LB), and AB media. The effect of 
biofilm formation was analysed in the poor nutrient media (AB medium) to mimic nutrient 
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conditions in the urinary tract, a nutritionally poor, nitrogen-rich environment (Alteri & 
Mobley, 2015), then compared with the one in the rich LB broth to find out whether nutrition 
could significantly affect biofilm density between the two media. The effect of aeration and 
nutrient on the biofilm formation process were also explored by incubating test strains under 
shaking and static conditions for all tested media and growth stages. Results showed that all 
of the above influenced biofilm formation timing and density.  
This work investigates the biofilm formation ability of the strains mentioned above by 
comparing their produced biofilms at the four different time-points depending on media and 
growth conditions (static and shaking). Statistical analyses were conducted to detect 
significant differences among those four time-points. 
In order to confirm that the biofilm density values are significantly different between the 
time-points for the specific strain, a one-way ANOVA statistical test was applied to calculate 
whether there is a significant difference in absorbency values, which represent biofilm 
density values. Data were sorted into tables of comparisons and strains were arranged into 
columns inside the tables along with the comparisons and their resultant p values. A p value 
of less than 0.01 was considered to be significant. One-way ANOVA statistical analysis 
results showed a significant difference (p < 0.01) in biofilm density values among time-points 
for all the tested strains, except K. pneumoniae SHV-18 grown in static AB and K. 
pneumoniae 9633 grown in shaking NB (Tables 2.I through 2.XII of Appendix). This 
indicates that the selected time-points (6, 12, 24, and 48 h) were ideal to be chosen for 
illustrating biofilm formation steps, as it showed it in distinctive stages. Moreover, there were 
considerable and significant variations in biofilm density values among tested strains. 
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Table 2.11 shows each strain’s biofilm at the maturation stage when grown in the different 
selected media under static and shaking conditions. Thus, it highlights the optimal conditions 
for each strain to produce the highest biofilm regarding the conditions mentioned above; for 
instance, E. coli TEM-3 produced the highest biofilm density with static incubation in AB 
medium. Specific strains did, however, exhibit a preference for growth media and stage. For 
example, K. pneumoniae SHV-18 produced the highest biofilm density when grown in NB, 
but when grown in AB medium, the produced biofilm was significantly lower. A possible 
explanation for this finding might be the variable nutrient contents of the media; in other 
words, genetic factors associated with biofilm formation were found to be affected by the 
nutrient composition of the growth medium (Stepanović et al., 2004; Reisner et al., 2006). In 
this study, static and shaking incubations were used to investigate the effects of aeration and 
nutrient distribution on biofilm.  
E. coli 12241 and K. pneumoniae 9633 were the non-resistant strains considered as a control 
to compare their biofilm density values and stages with other resistant tested strains. In this 
study, all tested strains showed the same pattern of biofilm formation as the non-resistant 
strain (except with E. coli CTX-M-15 and in some cases with K. pneumoniae OXA-48 and 
SHV-18) with the difference in biofilm density value. There are not enough studies that could 
categorically confirm a relationship between the antibiotic resistance and the ability to form 
high biofilm. Over the past two decades, many studies showed conflicting results. Abidi et 
al. studied 22 Pseudomonas aeruginosa isolates and inferred that biofilm production was 
significantly higher in MDR isolates (Abidi et al., 2013), while Eyoh et al. did not get similar 
results with MDR and non-MDR Staphylococcus aureus (Eyoh et al., 2014). Gurung et al., 
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however, studied 60 isolates and found a positive relationship between biofilm formation and 
antibiotic resistance while working with 60 isolates of Acinetobacter baumannii (Gurung et 
al., 2013). In this study, the resistant strains always formed a higher biofilm than the non-
resistant, and this might be one of the mechanisms that helped them to develop the resistance 
to escape the antibiotic effect through exposure to low levels of antimicrobials inside the 
biofilms (Ahmed et al., 2018). The Corehtash group surmised that this might be due to the 
delayed penetration of antimicrobial agents into the bacterial cell (Corehtash et al., 2015). 
Medium composition effects cannot solely increase or decrease antimicrobial tolerance, as 
one experiment showed that E. coli grown in LB medium was susceptible to kanamycin with 
little effect from glucose added to the medium, while a previous experiment on Pseudomonas 
aeruginosa demonstrated bacterial resistance to ampicillin in LB medium that was attenuated 
by the addition of glucose to the medium. These findings suggest that media composition can 
affect microbial physiology and thereby susceptibility to antimicrobials, while antimicrobial 
tolerance remains a unique characteristic of microbial biofilms (Stewart et al., 2000). 
Crystal violet was used to evaluate the density value of biofilm in early stages, bacterial 
attachment, and exopolysaccharides production. A basic dye, crystal violet attaches to 
remaining bacteria and exopolysaccharides that persist after washing with distilled water. 
Though it is a simple technique, the crystal violet assay is considered the gold standard for 
biofilm evaluation due to its extensive range of usage in the detection of bacterial and fungal 
biofilms (Crémet et al., 2013). Benefits include a high throughput of isolates, flexible 
protocol, and low cost (O'Toole, 2011). 
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Limitations of this study include a lack of microscopic examinations to confirm the presence 
or formation of exopolysaccharides during the four growth stages. We chose a crystal violet 
assay as the standard protocol for evaluations of early-stage biofilm formation (Reisner et 
al., 2006). This study illustrated the effect of certain parameters on the density values of 
biofilm produced by antibiotic-resistant strains of E. coli and K. pneumoniae. 
In summary, the antibiotic-resistant strains formed higher density of biofilm than the non-
resistant ones. The next question addressed by this experiment was whether variations in 
biofilm formation conditions correlated with expression patterns of genes associated with 
biofilm formation. Therefore, E. coli CTX-M-15 was selected for the next step to investigate 
the genetic role in biofilm formation during the selected time-points. 
 
 
 
 
 
 
 
 
 
 
 
 
116 
 
 
 
 
Chapter 3:  
Analysis of the gene expression during 
the biofilm formation in E. coli CTX-M-15 
at different growth conditions 
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3.1 Introduction 
 
The previous chapter of this work demonstrated the ability of specific antibiotic-resistant 
strains to form a biofilm, and the results showed that E. coli CTX-M-15 demonstrated 
variations in biofilm formation in different conditions, which highlights that this strain can 
adapt to many environments. Moreover, it is the most prevalent strain in the UK. For those 
reasons, E. coli CTX-M-15 was selected for the next step of this research.  
Work on this chapter focuses on identification of whether the variation in biofilm formation 
analysis observed among the selected time-points is correlated with the gene expression 
which is related to biofilm formation. Additionally, gene expression of the selected genes 
was attempted to be linked with the level of biofilm amount recorded during the four different 
growth stages of the selected strain grown in LB and AB. According to the Figure 3.1, biofilm 
amount recorded for the selected time-points formed consecutive rising and dropping levels 
for both media. Therefore, this chapter attempts to determine the related gene expression with 
each stage of biofilm time-point.  
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Fig 3.1 Comparison between biofilm amount formed in AB and LB broths during the four selected time-points 
(6, 12, 24, and 48 h) of growth in E. coli CTX-M-15. Numbers above the columns represent the p values of the 
t-test that was calculated to find out whether there is a significant difference between the biofilm formed among 
the two broths.  
 
For this analysis, genes that are related to biofilm development, QS, and antibiotic resistance 
were selected.  
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3.1.1 Aims and Objectives 
 
Aim 
 
The aim of this research was to analyse the expression of genes related to biofilm 
development, quorum-sensing controlled genes, and antibiotic resistance during various 
growth stages and in different growth conditions. 
 
Objectives  
 
• to grow the selected E. coli CTX-M-15 in AB and LB broth for 6 h, 12 h, 24 h, and 48 h 
• to extract the RNA from each of the above time-points for both media 
• to measure gene expression level using qPCR technique  
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3.2 Materials and methods 
 
3.2.1 Bacterial strain and culture conditions 
 
Antibiotic-resistant ESBL E. coli CTX-M-15 was used in this study, obtained from National 
Collection of Type Cultures (NCTC), cultured on nutrient agar plates, and incubated at 37°C 
for overnight. Prior to perform the assay, a loopful of bacterial colonies was inoculated into 
5 ml of LB and incubated for 18 h at 37°C in a static incubator. 
 
3.2.2 RNA isolation from biofilm 
 
The protocol of Atshan et al. (2013) was used with modifications and as follows: in order to 
measure gene expression of the selected genes in the two media, six-well TCP (Techno 
Plastic Products) were used in this assay. Two types of growth media were provided, namely 
LB broth and AB medium. Using a micropipette, the LB overnight static-incubated E. coli 
CTX-M-15 at 37°C were diluted to give a final OD600 of 0.01 in 5 ml in each well of the six-
wells TCPs that separately contain both media; AB and LB, and incubated at 37°C for 6 h, 
12 h, 24 h, and 48 h in a static incubator for each of the above-mentioned media to let the 
bacteria develop the various amounts of biofilm at each stage and in each medium. After 
incubation, the broth was carefully drawn from each well using a Pasteur pipette, and the 
wells were washed three times using a sterile distilled water. In each well of the TCP for each 
time-point in each medium, the adhered cells were disrupted by rapidly scraping them from 
the plate surface using a sterile micropipette tip until no visible layer was left, and suspended 
in cold sterile distilled water. The suspensions of each well were immediately transferred to 
Corning® 50 mL centrifuge tubes (Sigma Aldrich) and labelled according to the growth 
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medium and incubation time, and each tube was incubated with two volumes of RNA protect 
(Qiagen) according to the manufacturer instructions, vortexed for 5 s, and incubated for 5 
min at room temperature. The mixture was pelleted by centrifugation at 10000 x g for 10 
min, supernatant was decanted, and pellets were stored for a short period at -15°C awaiting 
RNA extraction (section 3.2.3). 
 
3.2.3 RNA extraction using Qiagen RNeasy Mini Kit 
 
The protocol for “Enzymatic Lysis of Bacteria” (Qiagen) was adhered to as follows: the 
recommended volume of TE buffer containing lysozyme was added to the pellets in the 50 
mL centrifuge tubes from the previous step, mixed by vortexing for 10 seconds, and 
incubated in a shaker incubator 25°C for 30 min. Buffer RLT was added according to the 
volume recommended by the manufacturer and vortexed vigorously, followed by addition of 
the appropriate volume of ethanol 70 %. Total RNA was isolated according to RNeasy mini 
kit (Qiagen) and as follows: up to 700 µl of each sample was transferred to an RNeasy Mini 
spin column placed in a 2 ml collection tube which is supported with the kit, labelled, and 
centrifuged for 15 s at 10000 x g in a refrigerated centrifuge, and the flow-through was 
discarded. 700μl of buffer RW1 was added to the RNeasy spin column and centrifuged for 
15 seconds at 10000 x g, and the flow-through was discarded. The spin column was placed 
into a new 2 ml collection tube and 500 μl of Buffer RPE was added and centrifuged for 15 
s at 10000 x g in a refrigerated centrifuge. Another 500 μl Buffer RPE was added and 
centrifuged for 2 min at 10000 x g. Finally, the spin column was placed into a new 1.5 ml 
collection tube and 50 μl RNase-free water was added directly to the spin column membrane 
122 
 
and centrifuged for 1 min at 10000 x g to elute the RNA. Using agarose gel electrophoresis 
and a NanoDrop™ Lite Spectrophotometer, the RNA quality and quantity were determined. 
RNase-free DNase set (Qiagen) was used to remove residual DNA after RNA elution. 
Resulting RNA samples were analysed for contaminating DNA present after enzyme 
treatment by PCR targeting the 16s rRNA gene; forward primer (5⸍-
CGGACTACGACGCACTTTAT-3⸍) and reverse primer (5⸍-
CGCAACCCTTATCCTTTGTTG-3⸍). PCR amplification reaction and conditions were the 
same as detailed in Table 2.5 and 2.6, with Tm of 55°C. PCR products were run on agarose 
gel electrophoresis to confirm the complete digestion of the contaminating DNA. Samples 
that showed bands were re-treated with DNase while samples that showed no bands were 
immediately converted into cDNA. 
 
3.2.4 Conversion of RNA to complementary DNA (cDNA)  
 
To avoid RNA degradation, purified RNA was converted immediately to cDNA using 
RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Scientific, Catalogue number: 
K1632) according to the manufacturer instructions and as follows: using random hexamer 
primers, the following ingredients were added for the final volume of 20 µl: Template RNA 
(after adjusting RNA quantity between 0.1 ng-5 µg), primers (random hexamers) 1 µl, and 
the total volume was completed to 12 µl nuclease-free water. Then, the following 
components were added in the following order: 5× reaction buffer 4 µl, RiboLock RNase 
Inhibitor 1 µl, 10 mM dNTP mix 2 µl, and RevertAid H Minus reverse transcriptase 1 µl. All 
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components were mixed gently and centrifuged, then incubated at 25°C for 5 min followed 
by 60 min at 42°C. The reaction was terminated by heating in a dry bath at 70°C for 5 min. 
 
 
3.2.5 Primers and their specificities for qPCR 
 
Genes’ sequences were obtained from the free software (NCBI), and their primers were 
designed using the free software of Integrated DNA Technologies (IDT). Optimum primer 
length was 18-22 bp, with a minimum product size of 80 bp and a maximum of 200 bp (Table 
3.1). cDNA obtained in 3.2.4 was used as the template for PCR reaction. PCR products were 
compared according to their fragment sizes with the expected designed fragment size after 
running on an agarose gel. The presence of primer-dimers and nonspecific amplification was 
identified through analysis of melting curve data.  
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Table 3.1 The list of primers that were used in this study. 
Genes Nucleotide sequence of primers (5'-3') *Type 
Annealing 
temperature 
Amplicon 
size (bp) 
Reference 
16s rRNA 
TAGCGGTGAAATGCGTAGAG REF 62 148 This study 
CCTCCAAGTCGACATCGTTTA  
   
blaCTX-M 
GGAATCTGACGCTGGGTAAA TRG 63 165 This study 
TATCGTTGGTGGTGCCATAG     
LuxS 
ATCCCTCTTTCTGGCATCAC TRG 63 143 This study 
AGCTTCACAGTCGATCATACC      
motB 
TGGATAGCGGCAAAGTGTTA TRG 63 98 This study 
CCTGTTCGGCTTGTTTGTTC     
crr 
TGTTCGTCCACTTCGGTATC TRG 62 146 This study 
CAGGGTAGACTTGGCTTTCT     
csgB 
CCGCAGCAGGTTATGATTTAG TRG 62 103 This study 
GTCCCAGCTTGACCAATTATG     
csgE 
CGCCGTTGAGGTAGAAGTC TRG 63 180 This study 
ACGTCCTGATTGACCGTTATT     
csgF 
GCGTGTCAAACATGCAGTAG TRG 63 200 This study 
ACGCTGAGGGTGTTTCAATA     
fliS 
AGAGAGCAAAGACGAACTAACC TRG 63 145 This study 
TTTCCAGGCATCGGCAATA      
motA 
AAGCCTTGGAGCACTCTATC TRG 62 110 This study 
CCTTCAGCGTGCCTTTAATC     
tolB 
TACGTCAGGTGGCTTCATTC TRG 63 176 This study 
GGTCGGTTCGGTATTGTTACT     
yieO 
ACGGTGGCGATGCTTATT TRG 63 82 This study 
GACTCACGGCAAGGGTAAA     
mdoH 
TGCTGTTCCATACGGTCTTC TRG 63 147 This study 
CAGCCCACACTAACCCTAAC     
 
*REF indicates reference gene, TRG indicates target gene 
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3.2.6 Primer efficiency 
 
The efficiency of each primer pairs was calculated using serial dilutions of amplicons (diluted 
1:100) in triplicate, then the resulting data were used to produce the standard curve for each 
primer set. A correlation coefficient (R2) of 0.99 or greater was preferred. The amplification 
efficiency = [10(-1/slope)] – 1.  The amplification efficiency of 80-120 % was preferred. 
 
3.2.7 Quantitative real-time PCR 
 
The RT-qPCR analysis was conducted using the Thermo Scientific™ PikoReal™ Real-Time 
PCR System. Each reaction contained 5 µl of SensiFASTTM SYBR® No-ROX Mix (Bioline), 
0.5 µl cDNA, 0.4 µl of forward and reverse primers each, and 3.7 µl of RT-PCR grade water 
(Thermo Fisher Scientific) in a total volume of 10 µl. Amplification conditions were as 
follows: 95 °C for 2 min followed by 40 cycles of 5 s at 95 °C, 10 s at 60 °C, and 10 s at 
72°C. The melting curve was obtained by melting the amplified template from 60 to 95°C. 
No-template control and no-reverse transcriptase control were included. For each sample, 
three technical replicates were used. All primer pairs’ amplification efficiency was evaluated 
using tenfold dilutions of pooled cDNA. Analysis followed MIQE guidelines (Bustin et al., 
2009). 
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3.2.8 No reverse transcriptase  
 
A no-reverse transcriptase control was used in triplicate for each sample (6 h, 12 h, 24 h, and 
48 h) by using the eluted pure RNA after the DNase treatment step without conversion into 
cDNA.  
 
3.2.9 Validation of the reference genes 
 
Four genes (16s rRNA, arcA, gapA, and rpoS) were chosen for potential stability as a 
reference gene by running qPCR for the four growth stages (6 h, 12 h, 24 h, and 48 h) in 
triplicate. A change in Cq value among the selected stages of less than 0.5 was accepted 
(Reid, 2018). Only one gene, 16s rRNA, was determined as a suitable reference gene. Due 
to time constraints, no more genes were tested for suitability as reference genes. The three 
genes that had failed as reference genes were then discarded. 
 
3.2.10 Data analysis using the relative standard curve method 
 
6 h of growth was used as the calibration sample to calculate the expression of the selected 
biofilm forming genes and AI-2 controlled genes at the 12, 24, and 48 h of growth in both 
AB and LB media. The X-fold change in the level of transcription was calculated using the 
relative standard curve method. Standard curves were made for both target and reference 
genes. Data were analysed using equations from Pikoreal software user manual (Thermo 
Scientific) that were put into the Excel sheet, and calculations for each gene studied were 
performed.  
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3.3 Results 
 
3.3.1 RNA integrity and stability 
 
Before starting any work with RNA, it is recommended to ensure the extracted RNA is intact 
and free from degradation. RNA integrity is a critical prefix step to obtain meaningful data 
of gene expression, while using low quality RNA could weaken the experimental results, for 
example, with qPCR expression analysis. Therefore, using intact RNA is a crucial element 
for the successful qPCR application (Fleige & Pfaffl, 2006). To check RNA integrity, 
extracted RNA samples were run on agarose gel, and samples that showed intense bands of 
16S and 23S rRNA indicated that the RNA in that sample was intact and not degraded.  
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Fig 3.2 The amount of the extracted RNA measured in nanogram per microliter. NanoDrop™ Lite 
Spectrophotometer used to determine the eluted RNA concentration. Also, the ration A260/A280 indicated that 
the eluted RNA sample was pure (in other words, >2).  
 
The RNA extracted at different time-points showed a satisfactory quality and quantity (Fig 
3.2-3.4). The cDNA synthesis produced large quantities.  
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Fig 3.3 Extracted and purified RNA run on 1 % agarose in TAE buffer showing the intensity and integrity of 
the two bands (23s and 16s). Both pictures show bright, separated bands with different intensities. A) The 
picture shows two samples; the first one with very low intensity, that is, with low RNA product, and the second 
sample with very dense bands. B) The picture shows extracted RNAs from different biofilm samples. Both 
pictures show intact RNA which is ready for the subsequent steps. The gel was run at 5 V/cm 
 
 
Fig 3.4 Gel electrophoresis (1 % agarose in TAE buffer) showing the purity of the extracted E. coli CTX-M-
15’s RNA samples (RNA 1 and RNA 2) after DNase treatment and PCR reaction. Electrophoresis results show 
the PCR products in which RNA samples used as the template after being treated with DNase to confirm the 
complete DNA digestion from the samples. A) The picture shows light bands (198bp) after DNase treatment, 
which indicates that there is still a small amount of contaminating DNA within the RNA sample. B) The picture 
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shows no bands for RNA 1 and 2, which means that both are free from contaminating DNA. The positive control 
(+ve) template was the E. coli CTX-M-15 genome DNA, and the negative control (-ve) had no template added. 
Primers used were the 16s rRNA as mentioned in 3.2.3. The gel was run at 5 V/cm 
 
3.3.2 Primers specificities  
 
The primers used in this work were tested for their specificities using end-point PCR with 
cDNA as the template for the reaction, and a Tm of 55 °C. Primers that showed a single band 
after running on agarose gel were selected for further qPCR expression analysis (Fig 3.5). 
 
Fig 3.5 PCR products of cDNA of the biofilm-related and quorum-sensing genes plus the housekeeping gene 
(16s rRNA) after running on 1 % agarose in TAE buffer. This experiment was performed before qPCR to 
confirm that the specific selected gene is expressing by showing a product (band) which comes from its cDNA 
that was added as the template for the PCR reaction mixture. Negative control was the 16s rRNA primers, which 
shows no bands. 5 V/cm. 
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3.3.3 Primers efficiencies 
 
The efficiency values for primers used for the gene expression analysis in this chapter ranged 
from ⁓92 % to ⁓106 %, which was within the range mentioned in 3.2.6 (80-120 %). The 
efficiency of Fig 3.6 below was ⁓100.5 % (Table 3.2). 
 
Fig 3.6 Example of a standard curve for the mdoH gene primers. Primer efficiency was calculated using serial 
dilutions of amplicons. In this example, each dot is composed of triplicate of the reaction mixture. 
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Table 3.2 The primers’ efficiencies used in the qPCR study. Serial dilutions of amplicons used to calculate the 
efficiencies. An efficiency of 80-120 % was accepted. 
Primer Efficiency in AB (%)  Efficiency in LB (%) 
16s 96.698 101.538 
crr 98.869 103.4 
csgB 96.563 105.816 
csgE 93.201 103.839 
csgF 95.639 99.799 
blaCTX-M 92.552 100.43 
fliS 103.003 103.711 
LuxS 95.621 93.764 
mdoH 100.464 101.211 
motA 92.65 100.017 
motB 95.428 102.344 
tolB 97.712 106.246 
yieO 99.759 98.293 
 
 
3.3.4 Expression levels of biofilm-associated genes quantified by qPCR 
 
The expression of 12 of the selected genes in both media AB and LB which were associated 
with biofilm formation were compared using the Cq values which showed significant 
differences among all genes and at every time-point of the selected growth stages. The mean 
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Cq values ranged from 15.45 to 31.84. The standard deviation of Cq values for each gene 
was less than 0.5. The comparative relative expression of the selected 12 genes at each growth 
stage of biofilm formation for the E. coli CTX-M-15 grown in AB and LB were calculated 
relative to the calibration samples (Table 3.3). In this experiment, not all genes worked in 
both media and gave a single peak in the melting curve analysis, that is, some gave the 
standard one peak in one medium but not in the other. Therefore, those genes that did not 
give a single peak were excluded from expression comparison in this chapter but kept for the 
other comparison in the next chapter where they gave an acceptable result.  
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Table 3.3 Fold change in mRNA level of antibiotic resistance coding gene, AI-2-related genes, and biofilm-
related genes in E. coli CTX-M-15 grown in LB and AB broth at different time-points of 12, 24, and 48 h. 
Downward arrows indicate significantly decreased gene expression and upward arrows indicate significantly 
increased gene expression when P-value < 0.05 (target sample differ to control). * indicates the target sample 
is not different from control (P-value > 0.05). 
Gene 
Fold Change in level of biofilm genes 
AB LB 
12 h 24 h 48 h 12 h 24 h 48 h 
16s (the reference gene) 1 1 1 1 1 1 
crr (D-glucosamine 
phosphotransferase system 
permease activity) 
0.05↓ 0.18↓ 0.05↓ 0.54↓ 1.26↑ 0.34↓ 
csgB (Curlin nucleator protein) 0.19↓ 419.76↑ 1.19* 0.66↓ 97.10↑ 59.89↑ 
csgE (Predicted transport 
protein) 
0.11↓ 3.96↑ 0.17↓ 1.08↑ 39.49↑ 3.03↑ 
csgF (Predicted transport 
protein) 
0.08↓ 4.00↑ 0.13↓ 1.60↑ 24.68↑ 2.63↑ 
blaCTX-M (β-lactam resistance) 0.15↓ 0.13↓ 0.03↓ 0.33↓ 0.23↓ 0.12↓ 
fliS (Flagellar protein 
potentiates polymerization) 
0.07↓ 0.55↓ 0.10↓ 0.05↓ 0.06↓ 0.01↓ 
LuxS (AI-2 synthase) 0.02↓ 0.08↓ 0.60↓ 0.69* 1.75↑ 0.25↓ 
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mdoH (Glucan biosynthesis: 
glycosyl transferase) 
0.04↓ 0.19↓ 0.05↓ 0.52↓ 2.41↑ 0.37↓ 
motA (a component of proton 
conductor of flagella motor) 
0.49↓ 0.74* 0.38↓ 0.07↓ 0.13↓ 0.01↓ 
motB (Protein rotates flagellar 
motor) 
0.11↓ 0.29↓ 0.22↓ 0.07↓ 0.22↓ 0.01↓ 
tolB (Periplasmic protein) 0.04↓ 0.31↓ 0.04↓ 0.56↓ 1.05* 0.15↓ 
yieO (Predicted multidrug or 
homocysteine efflux system) 
0.09↓ 0.43↓ 0.34↓ 0.09↓ 0.41↓ 0.06↓ 
 
All genes were downregulated at 12 h of growth in AB, while only two gave a significant 
upregulation in LB broth. Results in Table 3.3 represent qPCR values calibrated with 6 h of 
growth. In order to get a comprehensive overview for all selected genes’ upregulations and 
downregulations, relative expressions of all genes were plotted into line charts, and the p-
value was calculated for each time-point comparison to find out whether the upregulation 
and downregulation were significant (Fig 3.7). 
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Fig 3.7 The fluctuation of the transcriptional level of the selected genes (crr, csgB, csgE, csgF, blaCTX-M, fliS, 
LuxS, mdoH, motA, motB, tolB, and yieO) of E. coli CTX-M-15 growing in AB and LB broths at four time-
points (X-axis). Total RNA was isolated from 6, 12, 24, and 48 h of static incubation cultures from both AB 
and LB broths, and the relative expression levels of all of the above 12 genes were compared by qPCR (relative 
plotted against log 10, Y-axis). Data represent two independent experiments. Green lines represent gene 
expression in LB, and blue lines represent gene expression in AB. A t-test was used to detect the significant 
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difference in genes’ upregulations and downregulations between 12-24 and 24-48 h. Green dots refer to LB, 
and blue dots refer to AB. • p = 0.01-0.05, •• p = 0.001-0.01, ••• p = < 0.001. 
 
As shown in Fig 3.7, all genes were downregulated at 12 h, then upregulated at 24 h to go 
back to downregulation after 48 h of growth, which coincides with the phenotypic results 
observed during the biofilm development, with the exception of csgE and csgF in LB medium 
(as they slightly upregulated at 12 h) and blaCTX-M (as its level continued downward by time). 
Cq value of each gene has been plotted to get a clear picture of the expression level in each 
medium at each time-point (Fig 3.8 and 3.9). Cq values also correlate with biofilm 
development. A lower Cq value means higher expression and vice versa.  
 
. 
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Fig 3.8 The variations in Cq value of each of the selected genes which represent the copy number of the target 
gene as measured by RT-qPCR. High Cq value indicates a low copy number of the gene, while the low Cq 
value indicates a high copy number of the gene. Each color of the columns represents a specific time-point of 
growth in AB medium. The experiment was done in three technical replicates, and data represent the means of 
those biological replicates. Error bars represent the standard deviation of the triplicates. 
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Fig 3.9 The variations in Cq value of each of the selected genes which represent the copy number of the target 
gene as measured by RT-qPCR. High Cq value indicates a low copy number of the gene, while the low Cq 
value indicates a high copy number of the gene. Each color of the columns represents a specific time-point of 
growth in LB medium. The experiment was done in three technical replicates, and data represent the means of 
those biological replicates. Error bars represent the standard deviation of the mean. 
 
The expression of the selected genes at 12 h, 24 h, and 48 h was compared with that at 6 h to 
give a relative expression values for the selected time-points and for both media AB and LB, 
as shown in Fig 3.10 and 3.11 
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Fig 3.10 E. coli CTX-M-15 selected genes’ fold change at 12 h, 24 h, and 48 h of growth in AB broth.  
*csgB fold change at 24 h is shown separately on Fig 3.12. 
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Fig 3.11 E. coli CTX-M-15 selected genes’ fold change at 12 h, 24 h, and 48 h of growth in LB broth.  
*csgB fold change at 24 h and 48 h is shown separately on Fig 3.12. 
142 
 
 
 
Fig 3.12 Fold change of csgB in AB at 24 h and LB at 24 h and 48 h in E. coli CTX-M-15. 
 
3.4 Discussion 
 
The molecular mechanism of biofilm formation in E. coli, as well as its relationship with 
antimicrobial resistance, are poorly understood, and there are limited studies dealing with 
expression profiles of biofilm-related genes during biofilm formation stages, along with the 
expression of resistance genes. This chapter tries to link between the level of formed biofilm 
at each selected time-point of E. coli CTX-M-15 growing in AB and LB broth, with the level 
of gene expression measured at those above-mentioned time-points, to find out whether there 
is a correlation between the formed biofilm and gene expression level at that specific time-
143 
 
point, and to find out the connection of all of the above with the level of resistance during 
those time-points in different media.  
A crystal violet method for measuring biofilm amount in four different time-points was used 
as a comparative analysis (as changes in biofilm amount were significant among the selected 
time-points for the same medium) with the gene expression in both media at the same four 
time-points. In comparison with DNA microarray analysis and qPCR results reported in other 
studies dealing with E. coli biofilms (Schembri et al, 2003; Niba et al, 2007), there were 
neither time-points nor relative quantification for the specific gene at the different stages of 
biofilm formation in the selected E. coli K-12 used for those studies. The previous chapter 
results showed two peaks of high OD570 values for both media, AB and LB, which can give 
an assumption that there were two cycles of biofilm formation (Fig 3.1).  
Expression and upregulation of csgB, csgE, and csgF along with crystal violet OD570 results 
might give an indication for the timing of the attachment of bacterial cells to the surface, 
which is the first step in the biofilm formation process. csg gene clusters code for curli fibers 
and those clusters include two operons whose transcription is divergent; one operon encodes 
the csgA, csgB and csgC genes, while the other encodes csgD, csgE, csgF, and csgG. That 
might explain the difference in level and direction of expression obtained in this work 
(Hammar, 1996). Besides, results showed that media composition has a dramatic effect on 
timing and level of upregulation for those genes. The dramatic upregulation at 24 h for both 
media might indicate that this structure is a 3D mature biofilm and cells are on their initiation 
or through the detachment stage.   
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Relative expression of fliS with 6 h showed downregulation at 12 h, 24 h, and 48 h. There 
was a high significant upregulation at 24 h relative to 12 h in AB broth, while on LB it was 
slightly upregulated at the same time-point then dramatically downregulated. According to 
Fig 3.7, fliS has the highest level of expression at 6 h and 24 h (low Cq value). This might 
also suggest that those time-points with upregulations represent mature biofilms and cells are 
preparing for or at the detachment stage, as fliS has been reported to be indispensable for 
flagellation in E. coli and plays a significant role in motility (Kawagishi et al., 1992; Juhas 
et al., 2014). 
Barrios et al. (2006) found that AI-2 induces biofilm formation in E. coli, increased biofilm 
thickness and mass, and minimized interstitial space between microcolonies. He also wrote 
that adding AI-2 increased biofilm biomass produced by E. coli up to 30-fold. Our findings 
in this research matched with Barrios et al. (2006) results as biofilm mass was the highest 
during LuxS upregulations (Fig 3.7). 
As stated earlier, motA and motB are required for rotation of the flagellar motor, which is 
operated by H+ ions gradient across the cytoplasmic membrane in E. coli (Sowa et al., 2014). 
There was upregulation for both at 6 h and 24 h in LB broth, which is consistent with biofilm 
level and with fliS as they all contribute to motility. Thus, in AB medium, the motA was 
continuously expressed throughout growth during biofilm development. This was distinct 
only in AB broth, and this criterion might need further studies to get more knowledge about 
biofilms in poor media. It is not clear why there was no significant change in motA expression 
level among 12 h, 24 h, and 48 h in AB, nor between 24 h and 48 h for motB. However, this 
could be related to H+ in the minimal media which is comprised mostly of salts. 
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As reported by Kjeldsen et al. (2014), analysis of blaCTX-M-1 mRNA levels at different 
cefotaxime concentrations in antibiotic-resistant E. coli showed increased blaCTX-M-
1 expression when cefotaxime was present, and the expression of blaCTX-M-1 was cefotaxime 
concentration-dependent regardless of the growth phase. Based on that, over time expression 
decrease in both media might be due to the lack of cefotaxime or any related antibiotic(s) that 
might trigger the upregulation of the gene of resistance.  
crr showed a significant sequential up and down-regulation through the biofilm formation 
time-points and in both media. The upregulation timing at 6 h and 24 h synchronized with 
the peak of biofilm level clearly illustrates its role as being part of the phosphoenolpyruvate-
dependent sugar phosphotransferase system, as many studies showed the role of this system 
in sugar transport, sugar phosphorylation, bacterial virulence, and biofilm formation (Saier 
Jr, 2015; Horng, 2018; Lazazzera, 2010). 
mdoH expression was in the level of upregulation at 6 h and 24 h. This gene has been reported 
to be upregulated during biofilm formation (De Souza et al., 2004). This gene is involved in 
the biosynthesis of a protein called osmoregulated periplasmic glucan (OPG). OPG is 
required in the pathway of osmoregulated periplasmic glucan (OPG) biosynthesis, which is 
part of Glycan metabolism (UniProtKB, 2019a). Thus, these results might indicate that those 
time-points mentioned above and obtained from crystal violet assay represent real biofilm 
matrix.  
Along with crr and mdoH expression, tolB also showed a zig-zag relative expression at 6 h 
and 24 h upregulation, at the peak of formed biofilm. tolB is part of the Tol-pal gene cluster 
which codes for seven genes. This gene cluster’s encoded proteins seem to participate in 
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supporting the cell envelope integrity, but the precise task of the proteins in the cluster is still 
ambiguous. Mutation in this gene cluster yields a membrane with leaky functions, defects in 
cell division, and sensitivity to detergents and antibiotics (Lazzaroni et al, 1999; Vinés et al, 
2005; Llamas et al, 2000) Accordingly, upregulation of this gene at those time-points might 
show the importance of maintaining cell integrity during biofilm maturation, as the cell is 
going to be released to the outside environment where it cannot be protected anymore by the 
biofilm layer. The same might apply for yieO, which is proposed to be a multidrug transporter 
gene (Kvist et al., 2008), as it also showed a zig-zag relative expression at 6 h and 24 h 
upregulation. 
In summary, gene expression of biofilm-related and quorum sensing genes’ results showed 
some synchronisation with the peaks in both media under the four different time-points, that 
is, the variation in the biofilm development correlates with the variation of related gene 
expression. (Fig 3.7 through 3.9). 
The significance of this study comes as it illustrates not only genes that are expressed during 
biofilm formation but also shows their level of expression at different time-points. This might 
give more insights into the biofilm molecular biology which, in turn, might aid in finding a 
more efficient alternative medicine to treat biofilm-related infections or designing new drugs 
that target a specific time-point where the specific gene is upregulated or downregulated, a 
gene (or genes) whose expression plays a critical role in the biofilm formation process. 
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Chapter 4:  
Effect of Manuka honey on biofilm 
forming related gene expression in E. coli 
CTX-M-15  
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4.1 Introduction 
 
In this chapter, three types of Manuka honey (two from the same brand but differing in UMF 
and one from another brand) were tested for their antibacterial activity. Minimal inhibitory 
concentration (MIC), minimal biocidal concentration (MBC), and minimum biofilm 
elimination concentration (MBEC) were performed in order to determine the minimal 
concentration of the selected type that inhibit, stop the growth, and eliminate biofilm of the 
tested E. coli CTX-M-15 in AB broth respectively, as this broth mimics its natural 
environment as noted earlier (section 2.4).  
There are not enough studies addressing Manuka honey and its effect on bacterial gene 
expression, especially in relation to biofilm and antibiotic-resistant genes. Therefore, this 
work focuses mainly on how Manuka honey affects the expression of genes associated with 
biofilm formation on specifically selected virulence genes that are related to biofilm 
formation, AI-2 controlled genes, and the gene responsible for the antibiotic-resistance 
blaCTX-M-15 in the previously selected E. coli CTX-M-15. This might give an insight into the 
preferred target gene(s) for Manuka honey and, in turn, might aid in improving the best 
treatment and a better way to deliver it.  
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4.1.1 Aims and Objectives 
 
Aim 
 
The aim of this research was to test the antibacterial and antibiofilm ability of Manuka honey 
and to find out its effect on the level of gene expression of selected biofilm-related, quorum-
sensing-controlled, and antibiotic-resistant genes in E. coli CTX-M-15. 
 
Objectives  
 
• to test the antibacterial activity of three different Manuka honey types by measuring 
their zone of inhibition with E. coli CTX-M-15 
• to determine the MIC, MBC, and MBEC of the selected Manuka honey type 
• to measure the gene expression level of biofilm related genes, AI-2 controlled genes, 
and blaCTX-M-15 using the qPCR technique  
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4.2 Materials and methods 
 
4.2.1 Antibacterial activity of Manuka honey 
 
Three types of undiluted Manuka honey were tested for their antibacterial activity against E. 
coli CTX-M-15, two belonged to the same brand (Manuka Pharm®) but with different UMF 
and the other one belonged to a different brand (Steens™), using agar well diffusion assay 
and according to Boorn et al., 2010. Manuka Pharm® 24+ UMF and Manuka Pharm® 20+ 
UMF were purchased from Leicestershire, UK, while Steens™ Raw 24+ UMF Manuka 
honey was ordered online from New Zealand. 24+ UMF contained approximately 1122 
mg/kg MGO (Steenshoney.com, 2019), while 20+ UMF contained approximately 829 mg/kg 
MGO (Wallace et al., 2010). Briefly, MHA plates were prepared and inoculated with 0.5 
McFarland bacterial suspension (Absorbance was measured at 625 nm and ranged between 
0.08 and 0.13) from overnight-grown E. coli CTX-M-15 in NB, and a sterile cork borer of 6 
mm was used to make wells on each plate by completely removing the plug of agar right 
down to the plastic petri dish. 120 µl undiluted Manuka honey (which is the entire well size) 
was poured into each well to completely fill the entire well size, and the entire group was 
incubated overnight at 37°C. After incubation, the zone of inhibition was measured and 
recorded. This assay was performed in triplicate.  
 
4.2.2 Minimum inhibitory concentration of Manuka honey 
 
This was done using the microbroth dilution assay (% w/v) and according to Qamar et al., 
2018 with modifications. A loopful of E. coli CTX-M-15 colonies was inoculated into 5 ml 
151 
 
of LB and incubated overnight at 37°C in a static incubator. After incubation, cultures were 
adjusted to achieve 0.5 McFarland in AB medium (to mimic the natural site of E. coli CTX-
M-15 infection, section 2.4), then further diluted 1:100 with AB broth to achieve 1 × 105 
colony forming units (CFU)/ml. Serial dilutions of Steens Manuka honey were prepared in a 
sterile AB broth as a diluent to maintain ingredients concentrations. A 1 g/ml stock solution 
of Steens Manuka honey (50 %) was created. Serial dilutions in triplicates of the following 
concentrations (45, 40, 35, 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2, and 1 %) were created 
using AB broth. 100 µl of each of the Manuka honey dilution was added in 96 wells, flat 
bottom microtiter plate (Thermo Fisher Scientific), and 100 µl of the previously diluted 
bacterial suspension was added into each well for the above dilutions. Positive control 
contained AB broth with bacterial suspension and negative control contained only AB broth. 
All procedures were done in three biological replicates, and each biological replicate 
consisted of three technical replicates. The microtiter plate was incubated at 37°C for 24 h, 
after incubation, the MIC was calculated by comparison of each well with the positive and 
the negative controls wells by monitoring each well for having turbidity or being a clear using 
naked eye.  
 
4.2.3 Minimum bactericidal concentration (MBC) 
 
Minimum bactericidal concentration (% w/v) was performed to determine the lowest 
concentration of Manuka honey required to kill the antibiotic-resistant E. coli CTX-M-15. It 
is the first dilution with no growth on an agar plate (Sykes and Rankin, 2013). A 10 µl sample 
from microtiter plate wells of no visible growth was taken and plated on a nutrient agar plate 
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and incubated at 37 ⁰C for 24 h. After incubation, plates were examined, and any colony 
developed was scored as bacterial growth while no colonies developed was scored as no 
bacterial growth. All procedures were done in three biological replicates, and each biological 
replicate consisted of three technical replicates.  
 
4.2.4 Minimum biofilm elimination concentration (MBEC) 
 
In order to determine the lowest concentration of Manuka honey required to inhibit the 
formation of biofilm of the antibiotic-resistant E. coli CTX-M-15, the minimum biofilm 
elimination concentration was determined using the micro broth dilution method (% w/v) 
and according to Camplin and Maddocks (2014) with modifications. A loopful of E. coli 
CTX-M-15 colonies was inoculated into 5 ml of LB and incubated overnight at 37°C in a 
static incubator. After incubation, cultures were diluted to an OD600 of 0.01 in AB medium. 
Serial dilutions of Steens Manuka honey were prepared in a sterile AB broth as a diluent with 
positive controls (AB broth with bacterial suspension) and negative controls (only AB broth). 
Microtiter plates were prepared and incubated at 37°C for 24 h. After incubation, the broth 
was carefully drawn, and the wells were washed three times using a sterile PBS. Bacteria in 
wells were fixed by adding 200 µl of 99 % methanol for 15 min, then discarded and left to 
dry in an inverted position for 30 min at room temperature. 200 µl of 2 % crystal violet was 
used to stain each well for 5 min at room temperature. Excess stain was rinsed with sterilized 
distilled water. The remaining dye was re-solubilized with 160 µl of 33 % glacial acetic acid 
and left at room temperature for 30 min. Finally, optical density (OD570) for each well was 
measured using SpectraMax Plus 384 Spectrophotometer (Molecular Devices LLC). This 
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experiment was performed with three biological replicates, and each biological replicate 
consisted of three technical replicates.  
 
 
4.2.5 Biofilm formation assay using AB broth with 2 % Manuka honey 
 
2 % w/v of Steens Manuka honey was used to test the antibiofilm activity against E. coli 
CTX-M-15 grown in 6 wells TCPs in AB broth as, at this concentration, there is still a biofilm 
that can be produced and a significant difference in gene expression could be noticed, as there 
was a significant difference in biofilm produced after addition of 2 % Manuka honey 
compared with the biofilm without Manuka. The procedure was carried out as previously 
mentioned in 2.2.8 with the addition of 2 % w/v of Manuka honey and for three biological 
replicates. OD570 for each well was measured using Helios Gamma UV-Vis 
spectrophotometer and compared to the one grown on AB broth TCPs. 
 
4.2.6 Gene expression analysis on the effect of Manuka honey on the expression of 
biofilm-forming genes and AI-2 controlled genes 
 
4.2.6.1 RNA isolation and cDNA synthesis 
 
In order to compare the gene expressions between Manuka-treated and untreated samples, E. 
coli CTX-M-15 was inoculated twice into 20 ml of AB broth, once with 2 % Manuka honey 
and once with AB broth alone and according to the protocol of Wasfi et al. (2016) with 
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modifications. A volume of 20 ml of Manuka honey was prepared in AB broth at a sub-
inhibitory concentration (2 %) in Corning 50 ml centrifuge tubes (Sigma-Aldrich). An 
overnight culture of E. coli CTX-M-15 grown on LB was diluted 1:100 and grown on LB to 
mid-exponential phase. 500 µl of this culture was used to inoculate the 20 ml of Manuka 
honey solution and the AB broth and incubated at 37°C with shaking at 70 rpm for 3 h. After 
incubation, tubes were centrifuged at 10000 x g for 10 min and supernatant was decanted by 
pulling it using a pipette and keeping 2 ml of supernatant to maintain cell viability and not to 
degrade their RNA by adding the 2 volumes of RNAprotect Bacteria Reagent (Qiagen), 
vortexed immediately for 5 s, and incubated for 5 min at room temperature. The mixture was 
pelleted by centrifugation at 10000 x g for 10 min, supernatant was decanted, and pellets 
were stored for a short period at -15°C awaiting RNA extraction. 
 
4.2.6.2 RNA extraction using Qiagen RNeasy Mini Kit 
 
RNA extraction was performed as previously mentioned in 3.2.2 and 3.2.3. 
 
4.2.6.3 Conversion of RNA to complementary DNA (cDNA) 
 
Conversion of RNA to cDNA was performed as previously mentioned in 3.2.4. 
 
4.2.7 Quantitative real-time PCR 
 
The qPCR analysis was conducted using the Thermo Scientific™ PikoReal™ Real-Time 
PCR System. Reaction volumes and amplification conditions were the same as previously 
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mentioned in 3.2.7. No-template control and no-reverse transcriptase control were included. 
For each sample (treated and untreated), three technical replicates were used. All primer 
pairs’ amplification efficiency was evaluated using tenfold dilutions of pooled cDNA. 
Analysis followed MIQE guidelines (Bustin et al., 2009). 
4.2.7.1 No-reverse transcriptase  
 
A no-reverse transcriptase control was used in triplicate for each of the treated and untreated 
sample by using the eluted pure RNA after the DNase treatment step without conversion into 
cDNA.  
 
4.2.7.2 Validation of the reference genes 
 
As mentioned in 3.2.9, 16s rRNA was chosen for potential stability as a reference gene by 
running qPCR for the treated and untreated in triplicate for each. A change in Ct value among 
the selected stages of less than 0.5 was accepted (Reid, 2018).  
 
4.2.8 Data analysis using the relative standard curve method 
 
The untreated growth was used as the calibration sample to calculate the expression of the 
selected biofilm forming genes and AI-2 controlled genes in AB broth. The X-fold change in 
the level of transcription was calculated using the relative standard curve method. Standard 
curves were made for both target and reference genes. Data were analysed using equations 
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from Pikoreal software user manual (Thermo Scientific) that were put into an excel sheet, 
and calculations for each gene studied were performed.  
 
 
 
4.3 Results 
 
4.3.1 Antibacterial activity of Manuka honey 
 
This test was performed to determine the antibacterial activity of each of the tested Manuka 
honey brands by measuring the diameter of its inhibition zone. As expected, Manuka with 
UMF of +24 gave a significantly higher inhibition zone than the one of +20 (p-value <0.01). 
Steens +24 gave a noticeably higher inhibition zone than Manuka Pharm +24 (p-value 
<0.01). Table 4.1 below shows the mean values of the inhibition zone for the three brands. 
Table 4.1 Inhibition zone of Manuka honey measured in millimetres. Numbers in the inhibition zone column 
represent the mean values of triplicates ± standard deviation of the mean. 
Manuka brands Inhibition zone 
Manuka Pharm +20 11.6 ± 0.12 
Manuka Pharm +24 14.4 ± 0.06 
Steens +24 20.5 ± 0.1 
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4.3.2 Minimum inhibitory, bactericidal, and biofilm elimination concentration of 
Manuka honey 
 
Those tests (MIC, MBC, and MBEC) were performed to determine the minimal 
concentration of the selected Manuka honey required to cease the growth, kill, and eliminate 
biofilm of E. coli CTX-M-15, respectively. Manuka honey Steens +24 was used to measure 
the tests above as it gave the highest inhibition zone. To calculate the results, the mode was 
applied. Results showed that the MIC was at Manuka concentration of 6 %, where no well 
showed any turbidity. The MBC was at the concentration of 8 %, at which no growth showed 
on any of the nine agar plates. The MBEC, according to the absorbency measurements, was 
the well with 5 % concentration of Manuka honey, where there was no statistical difference 
in OD570 values with the control wells (p-value < 0.01). Table 4.2 show the results for MBC. 
 
Table 4.2 MBC data for Manuka honey on E. coli CTX-M-15. Three biological replicates were done with three 
technical replicates for each. N, no growth. G, growth.  
 Replicate 
Biological 
1 
Biological 
2 
Biological 
3  
8 % 
1 G N N 
MBC 2 N N N 
3 N N N 
7 % 
1 G N N  
2 N G G  
3 G N G  
6 % 
1 G G G  
2 G G G  
3 G G G  
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4.3.3 Biofilm formation assay using AB broth with 2 % Manuka honey 
 
MBEC results in section 4.3.2 showed that below 5 %  Manuka honey there is still some 
amount of biofilm that can be detected, and results in Fig 4.1 showed that treatment with 2 
% Manuka honey led to a significant fold decrease in biofilm density (Table 4.3). Therefore, 
to study the molecular mechanism of Manuka honey and its effect on the selected gene 
expression, 2 % was adopted for this purpose. Fig 4.1 below illustrates the difference in 
biofilm density for the four time-points with and without Manuka treatment (2 %). 
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Fig 4.1 The significant reduction (p-value < 0.01) in biofilm formation after treatment of E. coli CTX-M-15 
with 2 % Manuka honey. The graph shows the density of measured biofilm using OD570 for E. coli CTX-M-15 
grown in AB broth treated with 2 % Manuka (red columns) and untreated (blue columns). Error bars represent 
the standard deviation of the mean. 
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Table 4.3 The significant fold decrease in biofilm density in comparison between the 2 % Manuka honey treated 
and untreated E. coli CTX-M-15  
Time/Hours 
Approximate number of fold 
reduction 
6 17 
12 5 
24 7 
48 3 
 
4.3.4 RNA integrity and stability 
 
As previously illustrated in 3.3.1, extracted RNA samples from treated and untreated AB 
broth were run on agarose gel, and the sample that showed intense bands of 16S and 23S 
rRNA indicated that the RNA in that sample was intact and not degraded. Also, the extracted 
RNA from both broths showed satisfactory quality and quantity.  
 
 
4.3.5 Primers efficiencies 
 
The efficiency values for primers used for the gene expression analysis in this chapter ranged 
from ⁓95 % to ⁓107 %, which was within the range mentioned in 3.2.6 (80-120 %). (Table 
4.4). 
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Table 4.4 The primers’ efficiencies used in the qPCR study. Serial dilutions of amplicons used to calculate the 
efficiencies. An efficiency of 80-120 % was accepted. 
Gene Efficiency (%)  
16s 107.953 
crl 96.887 
crr 96.418 
csgB 103.256 
csgE 102.052 
csgF 107.567 
blaCTX-M 97.939 
fimA 99.546 
fliL 98.021 
fliS 99.581 
luxS 101.897 
motA 96.907 
motB 101.912 
nlpC 96.012 
rfaH 99.605 
tolB 97.613 
yieO 95.009 
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4.3.6 Expression levels of Manuka-treated and untreated E. coli CTX-M-15 virulence, 
AI-2 controlled, and antibiotic-resistance genes 
 
The expression level of 16 of the selected genes in both Manuka-treated and untreated AB 
broth were compared using the Ct values which showed significant differences among all 
genes in the comparison between treated and untreated. The mean Ct values for untreated 
AB broth ranged from 13.20 to 26.06, while for 2 % Manuka-treated ranged from 15.55 to 
26.38. The standard deviation of Ct values for each gene and for both treated and untreated 
was less than 0.5. 
Fig 4.2 shows the average Cq values as a measure of expression for these 17 genes for treated 
and untreated E. coli CTX-M-15. As can be seen clearly in this figure, treatment with 2 % 
Manuka caused a significant change (p-value < 0.05) in Cq values, either increasing or 
decreasing, which indicates a decrease and increase in gene expression, sequentially. 
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Fig 4.2 The comparison between the Cq values of Manuka-treated and untreated E. coli CTX-M-15 selected 
genes that represent the copy number of the target gene as measured by RT-qPCR. High Cq value indicates a 
low copy number of the gene, while the low Cq value indicates a high copy number of the gene. Manuka honey 
upregulated some genes (decreased their Cq value) and downregulated others (increased their Cq values). The 
experiment was done in three technical replicates, and data represent the means of those technical replicates. 
Error bars represent the standard deviation of the triplicates. (p-value < 0.05). 
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Fig 4.3 Bar chart shows the expression fold change (upregulation and downregulation) of the selected virulence 
genes, antibiotic-resistant gene, and AI-2 related genes in E. coli CTX-M-15 after treatment with 2 % Manuka 
in AB broth. The expression’s fold change results were normalized against the reference gene 16s rRNA and 
then were taken away from one to show the genes were upregulated and downregulated. 
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Table 4.5 Fold change in mRNA level of the selected virulence genes, antibiotic-resistant gene, and AI-2 related 
genes in E. coli CTX-M-15 after treatment with 2 % Manuka in AB broth. REF indicates reference gene. TRG 
indicates target gene; downward arrows indicate significantly decreased gene expression and upward arrows 
indicate significantly increased gene expression when P-value <0.05 (target sample differ to control).  
Gene 2 % Manuka 
16s (the reference gene) 1 
crl (Sigma factor-binding protein) 1.38↑ 
crr (D-glucosamine phosphotransferase system permease activity) 0.26↓ 
csgB (Curlin nucleator protein) 3.42↑ 
csgE (Predicted transport protein) 0.45↓ 
csgF (Predicted transport protein) 0.52↓ 
blaCTX-M (β-lactam resistance) 3.05↑ 
fimA (a major Type 1 subunit fimbrin) 0.20↓ 
fliL (Flagellar biosynthesis protein) 0.43↓ 
fliS (Flagellar protein potentiates polymerization) 0.10↓ 
LuxS (AI-2 synthase) 1.41↑ 
motA (Proton conductor component of flagella motor) 0.33↓ 
motB (Protein that rotates flagellar motor) 0.23↓ 
nlpC (Lipoprotein) 0.55↓ 
rfaH (DNA-binding transcriptional antiterminator) 3.97↑ 
tolB (Periplasmic protein) 0.66↓ 
yieO (Predicted homocysteine or multidrug efflux system) 1.64↑ 
165 
 
As shown in Fig 4.3 and Table 4.5, 2 % Manuka honey caused a significant downregulation 
(p-value < 0.05) in expression for the genes crr, csgE, csgF, fimA, fliL, fliS, motA, motB, 
nlpC, and tolB, while crl, csgB, blaCTX-M, luxS, rfaH, and yieO were significantly upregulated 
(p-value < 0.05).  
 
4.4 Discussion 
 
This work investigated the robust effect of Manuka honey by elucidating its inhibitory, 
biocidal, biofilm inhibition activity, and its mechanism of action against specific genes 
related to biofilm formation of E. coli CTX-M-15, the most prevalent antibiotic-resistant 
strains in the UK related to UTIs, and tried to find a good alternative for the current global 
issue of antibiotic resistance by testing the activity of Manuka honey concerning its 
inhibitory, biocidal, antibiofilm, and molecular mechanism effect on gene expression. This 
is the first study to detect the effect of Manuka honey on the antibiotic-resistant E. coli CTX-
M-15 that represents a rapidly evolving issue in the UK (Woodford et al., 2004).  
Many studies showed that plenty of genes are involved in biofilm formation and quorum-
sensing in UPEC. Hence, downregulating these genes’ expression could add to the efficiency 
of antibiotic treatment and could reduce the likelihood of treatment failure (Wasfi et al., 
2016). Three brands of Manuka honey were tested for their antibacterial activity using the 
agar well diffusion method.  
In this work, Steens™ Raw 24+ showed a significantly higher inhibition zone than Manuka 
Pharm® 24+, though both have the same UMF. Kwakman et al. (2011) showed that, after 
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neutralization of its MGO, the antimicrobial activity of Manuka honey against 
Staphylococcus aureus was reduced to a level of a honey-equivalent sugar solution. This 
indicated that MGO was responsible for Manuka’s honey potent antibacterial activity against 
Staphylococcus aureus. Moreover, they showed that 2-fold higher concentrations of MGO 
neutralized manuka honey was required to kill P. aeruginosa, while against E. coli the 
Manuka’s honey activity was not affected by neutralization of its MGO. The researchers 
deduced that MGO is not fully responsible for Manuka honey's non-peroxide antimicrobial 
activity, and it might be due to polyphenols or other components. This might explain why 
Steens™ Raw 24+ gave a significantly higher inhibition than Manuka Pharm® 24+, though 
both have the same UMF. Another study done by Lu et al. (2013 and 2014), who worked on 
many types of honey (including Manuka honey, alone and blended), and found that Manuka 
with the lowest MGO had the highest antibacterial activity against E. coli, Bacillus subtilis, 
and S. aureus, also confirmed the above conclusion. Paramasivan et al. (2014) reported that 
honeys from different geographical and floral sources show different effectiveness in 
antimicrobial activity even if they contain the same level of MGO, and this might be due to 
their differences in phenolic content. Results of this study were close to another study done 
by Idris and Afegbua (2017), which utilized the effect of Manuka honey on four ESBL E. 
coli different isolates which showed a mean zone of inhibition range between 16 and 18.4 
mm.  
In this research, MIC, MBC, and MBEC were performed using AB broth. The reason was to 
measure the effect of Manuka honey antibacterial activity against the tested antibiotic-
resistant strain in a media mimicking its natural site of infection in which there is a low 
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concentration of nutrients. Besides, AB broth was pre-selected to perform the following 
experiments regarding the gene expression analysis and the comparison of biofilm with and 
without Manuka honey for the tested strain. Despite the difference in media composition, 
MIC results of this study, which was 6 % w/v, were highly similar to another study done by 
Anand et al. (2019), who performed MIC test on Mueller Hinton Broth (MHB), and the result 
on E. coli was 6.25 % w/v, while the MBC result of this study, which was 8 %, did not match 
with the study mentioned above, in which the MBC was 12.5 %. This could be due to the 
nutrient content of MHB, which is more enriched compared to AB which, in turn, might give 
much growth support (Mast group, 2019), or the difference in Manuka’s antimicrobial 
contents.  
MBEC results showed that biofilm formation was eliminated at a concentration of 5 % of 
Manuka honey. To study the effect of Manuka honey of genetic expression for the genes 
related to biofilm formation, a concentration of 2 % (less than 5 %, which can significantly 
reduce biofilm formation but not eliminate it), was selected for further analysis.  
Several genes have been shown to play a role in E. coli virulence related to biofilm formation, 
and some are controlled by a quorum-sensing mechanism. Therefore, modulating the level 
of expression of those genes might add to the efficacy of antimicrobial therapy. Because of 
this, 12 genes related to biofilm formation, three genes related to and controlled by a quorum-
sensing mechanism, and one gene responsible for the antimicrobial resistance in E. coli CTX-
M-15 were selected, and their differential gene expression profiles in response to exposure 
to 2 % Manuka honey were determined using qPCR.  
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Many genes which were selected in this work (crr, csgB, csgE, csgF, fimA, fliL, fliS, motA, 
motB, nlpC, rfaH, tolB, and yieO) have been shown to be involved in the biofilm formation 
process in E. coli (Niba et al., 2007). Results from Table 3.3 and Fig 3.7 showed those genes 
were upregulated during biofilm formation. Current results show that crr, csgE, csgF, fimA, 
fliL, fliS, motA, motB, nlpC, and tolB were downregulated after 2 % Manuka honey 
treatment, whereas csgB, rfaH, and yieO were upregulated.  
crl codes for a protein that binds to ơs/RpoS, a sigma factor for stress response (Cavaliere 
and Norel, 2016). Since Manuka honey has been reported to display its antimicrobial effect 
through imposing high osmolarity to the microbial environment by its high sugar content to 
hinder the microbial growth (Mandal and Mandal, 2011), and since high osmolarity is a 
burden for microbial cells that drive their stress responses mechanisms of action (Moat et al., 
2003), stress response genes would therefore be switched on to cope with this environmental 
stress. Results showed an upregulation of crl after Manuka honey treatment, and this might 
confirm its vital role in stress response.  
Among the tested csg gene cluster, results showed that csgB has been upregulated, while the 
other tested genes csgE and csgF were downregulated. As mentioned before, both csgE and 
csgF are in one operon while csgB is in another operon, and each are regulated independently 
(Hammar et al., 1996; Barnhart and Chapman, 2006). Arnqvist et al. (1992) reported that crl 
stimulates transcription of csgBA operon through its promoter, and results of this work 
showed the upregulation of csgB, along with the upregulation of crl. Thus, results of this 
study agreed with those of Arnqvist et al., and that might explain the upregulation of csgB 
but not csgE and csgF. 
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Environmental factors, like osmolarity and pH, influence luxS expression (Delisa et al., 2001; 
Jeon et al., 2005). As stated above, Manuka honey imposes high osmolarity due to its sugar 
content. This might explain the upregulation of luxS after 2 % Manuka treatment. Besides, 
crl, which is controlled by AI-2, was also upregulated as stated above. This might elucidate 
the up-regulatory effect of stress conditions on specific co-related genes’ expressions. 
rfaH has been shown to repress biofilm formation by reduction of antigen 43 (Ag43) level. 
Ag43 mediated auto aggregation and biofilm formation, and it is encoded by flu, and rfaH 
has been shown to indirectly downregulate the expression of flu (Beloin et al., 2006). In these 
results, treatment with 2 % Manuka upregulated the expression of rfaH. 
yieO is a multidrug transporter gene and was shown to be upregulated along with other 
multidrug transporter and stress-related genes in a study done by Kvist et al. (2008) during 
biofilm formation, and the same study reported that the biofilm formation process exerts hard 
pressure on the cells due to the intracellular stress conditions. There is no available study 
confirming the exact function of its protein. In the previous results chapter, yieO was 
upregulated during the anabolic stage of biofilm (the peak). In this chapter, yieO was 
upregulated after treatment with 2 % Manuka honey. Thus, stress imposed by Manuka honey 
and probably the osmotic stress which induced stress-related genes could explain the 
upregulation of yieO. Multidrug efflux systems were reported to show abilities to transport 
various structurally unrelated drugs and other compounds and thus aid in drug resistance 
(Hayashi et al., 2014; Andersen et al., 2015). yieO belongs to the major facilitator super 
family with a transmembrane transport activity under the multidrug efflux system 
(UniProtKB, 2019d). Despite being specific to antibiotics, most efflux pumps are multidrug 
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transporters which can pump a wide range of unrelated compounds and hence, significantly 
contribute to multidrug resistance (Yilmaz et al., 2014; Andersen et al., 2015). 
Although there was no cefotaxime nor any related antibiotic added to the medium, qPCR 
results showed the upregulation of blaCTX-M, the gene of resistance, after 2 % Manuka 
treatment. Brudzynski and Sjaarda (2014) have examined the effects of Canadian honeys on 
ampicillin-resistant and ampicillin-sensitive E. coli strains. Results showed that both strains 
were sensitive to honey and displayed the same level of cell shape change, cytotoxicity, and 
endotoxin release. They concluded that both honey and ampicillin (which is a β–lactam 
antibiotic) induced similar structural changes to LPS and cell wall, and that this ability 
underlies antibacterial activities of both agents. Those effects resembled the action of β-
lactam antibiotics. So, in this study, Manuka honey might produce similar action as Canadian 
honeys by targeting the bacterial cell wall and, accordingly, upregulate blaCTX-M expression 
in an attempt for the latter to overcome the damaging effect on cell wall. However, another 
study done on P. aeruginosa exploring the effect of Manuka honey on its structure showed 
that cells were lysed, and SEM images showed short cells with cell surface abnormalities 
(Henriques et al., 2011). According to Brudzynski and Sjaarda’s explanation, Manuka and 
Canadian honeys have different cellular targets, and the Canadian honeys killed P. 
aeruginosa in a shorter time than Manuka did in the Henriques et al. study. In contrast to 
Brudzynski and Sjaarda’s findings, the upregulation of blaCTX-M up to three folds might 
support the idea that Manuka’s mechanism of action could resemble the one of β-lactam 
antibiotics, bearing in mind that the previous studies used different bacterial genera. 
171 
 
Nevertheless, more research on this topic needs to be undertaken before the association 
between blaCTX-M upregulation and Manuka treatment is more clearly understood.  
Another explanation for blaCTX-M upregulation is the effect of osmotic stress induced by 
Manuka’s high sugar content. Antibiotic resistance genes were evolved from genes having 
other functions and roles, and genes coding for multidrug resistance (MDR) transport 
proteins are among them (Cohen, 2014). In the responses to hyperosmotic stress, general 
stress regulators in E. coli such as RpoS and regulators of quorum-sensing collaborate and 
promote the overexpression of MDR transporters (Yang et al., 2006). Based on this, the 
above-mentioned factors promoting expression of MDR transporters might still be involved 
in blaCTX-M expression and upregulation. 
What was noticeable in this study is that motB which is under AI-2 control which has a role 
in biofilm formation (Delisa et al., 2001; Niba et al., 2007) was downregulated after 2 % 
Manuka honey treatment, thought luxS was upregulated. This might indicate that Manuka 
honey targets the biofilm-related genes. Thus, the current qPCR findings may suggest that 
the tested Manuka honey can prevent or disrupt E. coli CTX-M-15 biofilm. Our experimental 
results bear a close resemblance to those of Wasfi et al. (2016), who tested three types of 
honeys, and stated that all the tested honeys repressed biofilm-promoting genes and activated 
the expression of biofilm repressor genes.  
In summary, by comparing OD570 values between the treated and untreated E. coli CTX-M-
15, 2 % Manuka honey-treated cells showed a dramatic reduction of biofilm density. The 
obtained Cq values from the qPCR reaction of both treated and untreated samples clearly 
demonstrated that biofilm-related genes were downregulated. Accordingly, the antibiofilm 
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activity of Manuka honey might be due to its selective targeted actions against biofilm genes. 
Therefore, Manuka honey could be an effective alternative solution for the global issue of 
antibiotic-resistance and biofilm eradication. 
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Chapter 5:  
Overall Discussion and Conclusion 
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This work has demonstrated how biofilm density can be changed over four selected time-
points for two types of antibiotic-resistant bacterial species, E. coli and K. pneumoniae, 
compared with their wild-type species. The biofilms were found in higher densities in 
antibiotic-resistant strains than in non-resistant strains, which could be the reason why those 
strains have developed resistance as a biofilm confers resistance or tolerance. In addition, 
biofilm is a field where bacteria can exchange their genetic materials including resistance 
traits (Tenover, 2006).  
E. coli CTX-M-15 showed a variable ability to form a biofilm over the four time-points in 
the different media, which indicates its ability to adapt to many environmental conditions. 
This might explain why it is the most abundant UTI-causing strain in the UK (Hall and Mah, 
2017; Gebreyohannes et al., 2019). qPCR data showed that gene expression is correlated with 
biofilm development for both media, which means that E. coli CTX-M-15 can adapt to any 
environmental condition. This has created an urgent need to search for suitable antimicrobial 
therapy; hence, Manuka honey was suggested and tested for its antimicrobial and antibiofilm 
ability as it has not been tested against this antibiotic-resistant strain. 
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Chapter 6:  
Future work 
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Further work should include the examination of E. coli CTX-M-15 biofilm during the four 
time-points using a scanning electron microscope or confocal microscope to detect and 
exactly identify the biofilm stages during the four time-points regarding initial attachment, 
microcolony formation, biofilm maturation, and dispersion. Above all, this should give a 
better picture of any cellular damage imposed by Manuka honey. 
It is also recommended that biofilm densities for antibiotic-resistant strains with other types 
of ESBLs, such as PER and VEB-1 and carbapenemase SME and VIM, be measured, 
including other families of beta-lactamases, such as inhibitor-resistant and AmpC beta-
lactamases (Chaibi et al., 1999; Queenan and Bush, 2007; Jacoby, 2009; Paterson and 
Bonomo, 2005). 
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Fig 1.I CTX-M-15 gene sequence 
 
 
Fig 1.II IMP-type gene sequence 
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Fig 1.III KPC-3 gene sequence 
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Fig 1.V OXA-48 gene sequence 
 
 
Fig 1.VI SHV-18 gene sequence 
 
228 
 
 
 
 
 
Fig 1.VII TEM-3 gene sequence 
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Appendix II 
 
 
Table 2.I One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in AB medium with static incubation. According 
to the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth.  
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
E. coli IMP-
type 0.050 0.134 0.205 0.112 0.0006 Yes 
E. coli CTX-
M-15 0.665 0.271 0.376 0.216 
< 
0.0001 Yes 
E. coli TEM-3 0.324 0.474 0.644 0.511 
< 
0.0001 Yes 
E. coli 12241 0.041 0.097 0.131 0.059 0.0002 Yes 
 
 
Table 2.II One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in AB medium with static incubation. 
According to the data shown, all K. pneumoniae strains showed a significant difference in biofilm density values 
when comparing their growth between the four different time-points of growth. 
 
 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
K. pneumoniae 
OXA-48 0.198 0.255 0.372 0.326 < 0.0001 Yes 
K. pneumoniae 
SHV-18 0.169 0.197 0.154 0.185 0.0358 No 
K. pneumoniae 
NDM-1 0.159 0.228 0.359 0.296 < 0.0001 Yes 
K. pneumoniae 
KPC-3 0.227 0.267 0.414 0.284 < 0.0001 Yes 
K. pneumoniae 
9633 0.014 0.025 0.063 0.038 0.0010 Yes 
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Table 2.III One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in AB medium with shaking incubation. According 
to the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth. 
 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
E. coli IMP-
type 0.039 0.055 0.082 0.024 
< 
0.0001 Yes 
E. coli CTX-
M-15 0.113 0.083 0.064 0.028 
< 
0.0001 Yes 
E. coli TEM-3 0.038 0.049 0.089 0.044 
< 
0.0001 Yes 
E. coli 12241 0.025 0.044 0.066 0.021 
< 
0.0001 Yes 
 
 
Table 2.IV One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in AB medium with shaking incubation. 
According to the data shown, all K. pneumoniae strains showed a significant difference in biofilm density values 
when comparing their growth between the four different time-points of growth. 
 
 
 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
K. pneumoniae 
OXA-48 0.291 0.516 0.255 0.395 < 0.0001 Yes 
K. pneumoniae 
SHV-18 0.196 0.370 0.171 0.291 < 0.0001 Yes 
K. pneumoniae 
NDM-1 0.255 0.428 0.699 0.634 < 0.0001 Yes 
K. pneumoniae 
KPC-3 0.312 0.498 0.715 0.493 < 0.0001 Yes 
K. pneumoniae 
9633 0.025 0.041 0.072 0.054 < 0.0001 Yes 
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Table 2.V One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in LB medium with static incubation. According to 
the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth. 
 
 
 
Table 2.VI One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in LB medium with static incubation. 
According to the data shown, all K. pneumoniae strains showed a significant difference in biofilm density values 
when comparing their growth between the four different time-points of growth. 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
K. pneumoniae 
OXA-48 0.227 0.065 0.355 0.144 < 0.0001 Yes 
K. pneumoniae 
SHV-18 0.428 0.293 0.562 0.328 < 0.0001 Yes 
K. pneumoniae 
NDM-1 0.217 0.271 0.309 0.292 0.0006 Yes 
K. pneumoniae 
KPC-3 0.370 0.456 0.505 0.473 < 0.0001 Yes 
K. pneumoniae 
9633 0.016 0.037 0.058 0.042 0.0081 Yes 
 
 
 
 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value 
significant (p < 
0.01) 
E. coli IMP-type 0.478 0.406 0.342 0.181 < 0.0001 Yes 
E. coli CTX-M-15 0.611 0.225 0.410 0.089 < 0.0001 Yes 
E. coli TEM-3 0.511 0.376 0.270 0.081 < 0.0001 Yes 
E. coli 12241 0.345 0.305 0.239 0.082 < 0.0001 Yes 
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Table 2.VII One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in LB medium with shaking incubation. According 
to the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth. 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
E. coli IMP-
type 0.122 0.224 0.026 0.103 
< 
0.0001 Yes 
E. coli CTX-
M-15 0.614 0.601 0.179 0.072 
< 
0.0001 Yes 
E. coli TEM-
3 0.190 0.256 0.088 0.129 
< 
0.0001 Yes 
E. coli 12241 0.100 0.173 0.012 0.082 
< 
0.0001 Yes 
 
 
Table 2.VIII One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in LB medium with shaking incubation. 
According to the data shown, all K. pneumoniae strains showed a significant difference in biofilm density values 
when comparing their growth between the four different time-points of growth. 
Strain 
mean 6 
h mean 12 h 
mean 
24 h mean 48 h p-value significant (p < 0.01) 
K. pneumoniae 
OXA-48 0.438 0.391 0.352 0.376 
< 
0.0001 Yes 
K. pneumoniae 
SHV-18 0.412 0.357 0.268 0.294 
< 
0.0001 Yes 
K. pneumoniae 
NDM-1 0.576 0.426 0.340 0.392 
< 
0.0001 Yes 
K. pneumoniae 
KPC-3 0.624 0.547 0.456 0.500 
< 
0.0001 Yes 
K. pneumoniae 9633 0.103 0.074 0.033 0.068 
< 
0.0001 Yes 
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Table 2.IX One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in NB medium with static incubation. According 
to the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth. 
Strain mean 6 h 
mean 12 
h 
mean 24 
h 
mean 48 
h p-value 
significant (p < 
0.01) 
E. coli IMP-
type 0.097 0.190 0.110 0.056 0.0001 Yes 
E. coli CTX-M-
15 0.310 0.350 0.209 0.237 
< 
0.0001 Yes 
E. coli TEM-3 0.184 0.339 0.139 0.063 
< 
0.0001 Yes 
E. coli 12241 0.074 0.117 0.076 0.046 0.0004 Yes 
 
 
Table 2.X One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in NB medium with static incubation. 
According to the data shown, all K. pneumoniae strains (except 9600) showed a significant difference in biofilm 
density values when comparing their growth between the four different time-points of growth. 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value significant (p < 0.01) 
K. pneumoniae 
OXA-48 0.221 0.618 0.686 0.624 
< 
0.0001 Yes 
K. pneumoniae 
SHV-18 0.452 0.646 0.735 0.643 
< 
0.0001 Yes 
K. pneumoniae 
NDM-1 0.253 0.549 0.634 0.560 
< 
0.0001 Yes 
K. pneumoniae 
KPC-3 0.462 0.785 0.884 0.815 
< 
0.0001 Yes 
K. pneumoniae 
9633 0.025 0.082 0.102 0.089 0.0011 Yes 
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Table 2.XI One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for E. coli strains grown in NB medium with shaking incubation. According 
to the data shown, all E. coli strains showed a significant difference in biofilm density values when comparing 
their growth between the four different time-points of growth. 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value 
significant (p < 
0.01) 
E. coli IMP-type 0.156 0.000 0.059 0.021 < 0.0001 Yes 
E. coli CTX-M-15 0.320 0.127 0.069 0.028 < 0.0001 Yes 
E. coli TEM-3 0.089 0.000 0.063 0.033 < 0.0001 Yes 
E. coli 12241 0.073 0.000 0.047 0.015 0.0015 Yes 
 
 
 
 
Table 2.XII One-way ANOVA showing the significance of differences in biofilm density values among four 
growth stages (6, 12, 24, and 48 h) for K. pneumoniae strains grown in NB medium with shaking incubation. 
According to the data shown, all K. pneumoniae strains showed a significant difference in biofilm density values 
when comparing their growth between the four different time-points of growth. 
 
 
 
 
 
 
Strain mean 6 h mean 12 h mean 24 h mean 48 h p-value 
significant (p 
< 0.01) 
K. pneumoniae OXA-48 0.413 0.200 0.287 0.219 < 0.0001 Yes 
K. pneumoniae SHV-18 0.645 0.266 0.453 0.281 < 0.0001 Yes 
K. pneumoniae NDM-1 0.628 0.324 0.548 0.373 < 0.0001 Yes 
K. pneumoniae KPC-3 0.673 0.263 0.649 0.312 < 0.0001 Yes 
K. pneumoniae 9633 0.110 0.051 0.090 0.061 0.0514 No 
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Appendix III 
Standard curves for the calculation of the primer efficiency in AB broth 
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Standard curves for the calculation of the primer efficiency in LB broth 
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Appendix IV 
 
Example of a Ct value obtained from this study 
 
 
 
Example of a melting curve obtained from this study 
 
